PUBLICATIONS Book Chapters 1) Non-Alcoholic Fatty Pancreatic Disease (NAFPD). Authors: Alhareth Al Juboori, Harleen Chela, Sami Samiullah, Veysel Tahan. Book Title: Obesity and Diabetes: New Surgical and Nonsurgical Approaches. Editors: Faintuch, Joel, Faintuch, Salomão (Eds.). Chapter 25; pages 335- 345; 2020 Springer Nature Switzerland AG. Springer is part of Springer Nature. 2) Management of Interferon-Free Direct-Acting HCV Antiviral Therapy Failure. Authors: Tran KD, Albarrak AA, Tahan V. Book Title: Chronic HCV. Editors: Resat Ozaras (Eds.) 2019 Springer Nature Switzerland AG. Springer is part of Springer Nature. ISBN 978-3-030-03757-4. April 7, 2019. 3) Current Therapy of Chronic Hepatitis C Virus in Treatment Naive Patients. Authors: Juboori AA, Satinder Kaur, Tahan V. Book Title: Chronic HCV. Editors: Resat Ozaras (Eds.) 2019 Springer Nature Switzerland AG. Springer is part of Springer Nature. ISBN 978-3-030-03757-4. April 7, 2019. 4) Acute Hepatitis: Acute Hepatitis A. Authors: Turse EP, Rossow B, Tahan V. Book Title: Viral Hepatitis. Springer, Editors: Resat Ozaras (Eds.) © 2019 Springer Nature Switzerland AG. Springer is part of Springer Nature. ISBN 978-3- 030-03535-8. March 6, 2019. 5) Natural History of Hepatitis B Virus. Authors: Heath RD, Tahan V. Book Title: Viral Hepatitis: Chronic Hepatitis B. Editors: Resat Ozaras, Veysel Tahan (Eds.) © 2018 Springer Nature Switzerland AG. Springer is part of Springer Nature. Pages: 1-10. ISBN 978-3-319-93449-5. September 2018. 6) Hepatitis D Virus Infection: Role of Hepatitis B and the Current Updates on Management. Authors: Albarrak AA, Tran KD, Tahan V. Book Title: Viral Hepatitis: Chronic Hepatitis B. Editors: Resat Ozaras, Veysel Tahan (Eds.) © 2018 Springer Nature Switzerland AG. Springer is part of Springer Nature. Pages: 95-103. ISBN 978-3-319-93449-5. September 2018. 7) Skvorak K, Gramignoli R, Hansel MC, Uraz S, Tahan V, Dorko K, Marongiu F, and Strom SC. Cell Transplantation: a possible alternative to orthotopic liver transplant (OLT). Book Title: In Liver Transplantation - Technical Issues and Complications. Pages: 143-172H. Editors: Abdeldayem, and N.A.A. Allam, InTech. Dubrownick. 2012. 8) Gramignoli R, Marongiu F, Miki T, Skvorak KJ, Tahan V, Dorko K, Hansel MC, Davila JC, Ellis ECS, Strom SC. Human Placenta Cell Isolation. Book Title: Methods in Bioengineering: Methods in Cell Transplantation 2011; Chapter 12, page 183-198. Editors: Soto-Gutierrez A, Navarro-Alvarez N, Fox IJ. Artech House Editorial. Pittsburgh. 9) Tozun N, Ersoy O, Eren F, Tahan V. Epidemiology and Diagnosis of Hepatitis B in the Mediterranean Region and Elsewhere. Book Title: Detection of Bacteria, Viruses, Parasites and Fungi. Editor: Mariapia Viola Magni. Springer: NATO - Science for Peace and Security Series A: Chemistry and Biology. 1st Edition, 2010, VII, pages: 239-260. Amsterdam, Netherland. ISBN: 978-90-481-8543-6.

Published articles in National/International Medical Journals (2015-present)

1) Naseer M, Hadi S, Syed A, Safdari A, Tahan V, Exosomes: A new frontier under the spotlight for diagnosis and treatment of gastrointestinal diseases. World J Meta-Anal 2021; 9(1): 12 28. 2) Tarar Z, Tahan V, Yin F, Daglilar E. An Unusual Case of Esophageal Hyperplastic Polyp with Scleroderma: A Case Report and Review of the Literature. Cureus 2021; 13(1): e12500. doi:10.7759/cureus.12500. 3) Chela HK, Tahan V, Daglilar E. Do not hammer a wrench: remove endoscopically. Radiol Case Rep. 2020; 16(1):219. doi: 10.1016/j.radcr.2020.10.036. 4) Parsa N, Grisham EA, Cockerell CJ, Matteson-Kome ML, Bysani RV, Samiullah S, Nguyen DL, Tahan V, Ghouri YA, Puli SR, Bechtold ML. Split-dose vs same-day bowel preparation for afternoon colonoscopies: A meta-analysis of randomized controlled trials. World J Meta-Anal 2020; 8(6): 0-0 DOI: 10.13105/wjma.v8.i6.0000 5) Daglilar E, Connolly SE, Tahan V, Cohen A, Therapondos G. The Utilization and Diagnostic Yield of Upper Endoscopy for Evaluation of Gastrointestinal Symptoms Within the First Year After Liver Transplantation. Cureus. 2020: 12(11):e11323. doi: 10.7759/cureus.11323. PMID: 33282596; PMCID: PMC7717078. 6) Akin H, Kurt R, Tufan F, Swi A, Ozaras R, Tahan V, Hammoud G. Newly Reported Studies on the Increase in Gastrointestinal Symptom Prevalence with COVID-19 Infection: A Comprehensive Systematic Review and Meta- Analysis. Diseases. 2020;8(4):41. doi: 10.3390/diseases8040041, This article has been the most extensive metaanalysis and systematic review on COVID-19 related GI symptoms in the literature. 7) Chela HK, Pasha SB, Basar O, Daglilar E, Tahan V. Liver in the limelight in the corona (COVID-19) time. World J Clin Cases. 2020;8(16):3405-3410. We reviewed COVID-19 related liver findings. 8) Naseer M, Poola S, Dailey FE, Akin H, Tahan V. Implications of COVID-19 for inflammatory bowel disease: Opportunities and challenges amidst the pandemic. World J Meta-Anal. Oct 28, 2020; 8(5): 383-399.IBD and COVID- 19 interferance was discussed. 9) Ghouri YA, Tahan V, Shen B. Secondary causes of inflammatory bowel disease. W. J Gastroenterol. 2020; 26(28):3998-4017. 10) Ali S, Tahan V, Abdel Jalil A. Earl buried bumper syndrome: A rare complication of percutaneous endoscopic gastrostomy tube placement. Cureus. 2020;12: e9177. 11) Chela H, Romana BS, Madabattula M, Albarrak AA, Yousef MH, Samiullah S, Tahan V. Stem cell therapy: a potential for the perils of pancreatitis. Turk J Gastroenterol 2020; 31;414-24. . 12) Abu Khalaf S. Albarrak A, Yousef M, Tahan V. Immune checkpoint inhibitors induced colitis, stay vigilant: A case report. W J Gastrointestinal Oncol 2020; 12:699-704. 13) Naseer M, Poola S, Ali S, Samiullah S, Tahan V. Prebiotics and Probiotics in Inflammatory Bowel Disease (IBD): Where Are We Now And Where Are We Going? Curr Clin Pharmacol. 2020;15(3):216-233. 14) Naseer M, Poola S, Uraz S, Tahan V. Therapeutic Effects of Prebiotics in Constipation: A Review. Curr Clin Pharmacol. 2020;15(3):207-215. 15) Tahan V, Tran K, Yousef MA, Dailey FE, Uraz S. Correction: An unusual finding of a ladybug on screening colonoscopy. ACG Case Rep J 2019; 6:270. 16) Tahan V, Tran K, Yousef MA, Dailey FE, Uraz S. An unusual finding of a ladybug on screening colonoscopy. ACG Case Rep J 2019; 6:1. 17) Jalil AA, Gorski R, Abdel Jalil SA, Cronin R, Comianos M, Mann M, Rajagopalan H, Jalil AA, Tahan V. Factors associated with diverticular bleeding and re-bleeding: A United States hospital study. North Clin Istanb 2019; 6(3):248- 253. 18) Dailey FE, Turse EP, Daglilar E, Tahan V. The dirty aspects of fecal microbiota transplantation: a review of its adverse effects and complications. Current Opinion in Pharmacology 2019;49:29-33. (Elsevier J. IF: 6.313). 19) Turse EP, Dailey FE, Ghouri Y, Tahan V. Fecal microbiota transplantation donation: the gift that keeps on giving. Current Opinion in Pharmacology 2019;49:24-28. (Elsevier J. IF: 6.313). 20) Albarrak AA, Romana BS, Uraz S, Yousef MH, Juboori AA, Tahan V. Clostridium difficile infection in inflammatory bowel disease patients. Endocr Metab Immune Disord Drug Targets. 2019;19(7):929-935. 21) Dailey FE, Turse EP, Rossow B, Kuwajima VK, Tahan V. Probiotics for gastrointestinal and liver diseases: an updated review of the published literature. Endocr Metab Immune Disord Drug Targets 2019;19(5):549-570. 22) Naseer M, Turse EP, Syed A, Dailey FE, Zatreh M, Tahan V. Interventions to improve sarcopenia in cirrhosis: A systematic review. World J Clin Cases 2019; 7(2): 156-170. (This systematic review is the most up-to-date paper underlining the importance of sarcopenia in cirrhosis by my mentorship with the current MU GI Team). 23) Rao SC, Sathyamurty A, Turse EP, Dailey FE, Tahan V. Extra-thoracic Extrinsic Compression: An Unusual Cause of Dysphagia. Endocr Metab Immune Disord Drug Targets. Endocr Metab Immune Disord Drug Targets. 2019;19:230- 231. 24) Heath RD, Parsa N, Matteson-Kome ML, Buescher V, Samiullah S, Nguyen DL, Tahan V, Ghouri YA, Puli SR, Bechtold ML. Use of music during colonoscopy: An updated meta-analysis of randomized controlled trials. World J Meta-Anal 2019; 7: 428-435. 25) Turse EP, Dailey FE, Naseer M, Partyka EK, Bragg JD, Tahan V. Stem cells for luminal, fistulizing, and perianal inflammatory bowel disease: a comprehensive updated review of the literature. Stem Cells Cloning 2018;11:95-113. 26) Romana BS, Albarrak AA, Yousef MH, Tahan V. Infliximab use in ulcerative colitis flare with Clostridium difficile infection: A report of two cases and literature review. North Clin Istanb 2018; 5(3): 256-260. 27) Turse EP, Dailey FE, Naseer M, Partyka EK, Tahan V. One more chance of fistula healing in IBD: Stem cell therapy. World J Clin Cases 2018:6(12):493-500. 28) Dailey FE, Turse EP, Naseer M, Bragg JD, Tahan V. Review of stem cells as promising therapy for perianal disease in inflammatory bowel disease. World J Transplant 2018;8(4):97-101. 29) Romana B, Chela H, Dailey F, Nassir F, Tahan V. Non-alcoholic fatty pancreas disease (NAFPD): A silent spectator or the fifth component of metabolic syndrome? A literature review. Endocr Metab Immune Disord Drug Targets. 2018;18(6):547-554. 30) Naseer M, Daily F, Al Juboori AH, Samiullah S, Tahan V. Epidemiology, determinants, and management of AIDS cholangiopathy: A review. Worl J Gastroenterol 2018;24(7):767-774. 31) Heath RD, Ibdah JA, Tahan V. Fecal Microbiota Transplantation and Its Potential Therapeutic Uses in Gastrointestinal Disorders. North Clin Istanb 2018;5(1):79-88. 32) Mir FA, Al Juboori A, Bragg JD, Tahan V. Autoimmune hemolytic anemia associated with infliximab use in ulcerative colitis. North Clin Istanb 2018;5(1):64-66. 33) Romana SB, Tahan V. Rifaximin for irritable bowel syndrome treatment. Atlas of Science. November 17, 2017, https://atlasofscience.org/rifaximin-for-irritable-bowel-syndrome-treatment/, 34) Heath RD, Ertem F, Romana BS, Ibdah JA, Tahan V. Hepatocyte Transplantation: Consider Infusion Before Incision. Word J Transplant. 2017;7:317-323. 35) Chela H, Yousef MH, Albarrak AA, Romana BS, Hudhud DH, Tahan V. Elderly donor graft for liver transplantation: Never too late. Word J Transplant. 2017;7:324-328. 36) Yousef MH, Al Juboori A, Albarrak AA, Ibdah JA, Tahan V. Fatty liver without a large “belly”: magnified review of non- alcoholic fatty liver disease in non-obese patients. World J Gastrointest Pathophysiol 2017; 8: 100-107. 37) Ahmed K, Almashhrawi A, Ibdah JA, Tahan V. Is the 25-year hepatitis C marathon coming to an end to declare victory? World J Hepatol 2017;9:921-929. 38) Mir F, Yousef MH, Partyka EK, Tahan V. Successful treatment of chronic refractory pouchitis with vedolizumab. Int J Colorectal Dis 2017;32:1517-1518. 39) Winn JN, Sathyamurthy A, Kneib JL, Ibdah JA, Tahan V. Synchronous gastrointestinal carcinoid tumor and colon adenocarcinoma: Case reports and literature review. Am J Case Rep 2017;18:632-636. 40) Heath RD, Brahmbhatt M, Tahan AC, Ibdah JA, Tahan V. Coffee: The magical bean for liver diseases. World J Hepatol 2017;9:689-696. 41) Mir F, Kahveci AS, Ibdah JA, Tahan V. Sofosbuvir/velpatasvir regimen promises an effective pan-genotypic HCV Cure. Drug Des Devel Ther 2017;11:497-502. 42) Rao SC, Ashraf I, Mir F, Samiullah S, Ibdah JA, Tahan V. Dual infection with hepatitis B and Epstein-Barr virus presenting with severe jaundice, coagulopathy and hepatitis B virus chronicity outcome. Am J Case Rep 2017;18:170- 172. 43) Mir F, Achakzai I, Ibdah JA, Tahan V. Undigested pills in stool mimicking parasitic infection. Case Rep Gastrointestinal Med. 2017:3718954. 44) Romana B, Tahan V. Rifaximin in treatment of patients with Irritable bowel syndrome. Turk J Gastroenterol 2017;28:77-78. 45) Soltys KA, Setoyama K, Tafaleng EN, Soto Gutiérrez A, Fong J, Fukumitsu K, Nishikawa T, Nagaya M, Sada R, Haberman K, Gramignoli R, Dorko K, Tahan V, Dreyzin A, Baskin K, Crowley JJ, Quader MA, Deutsch M, Ashokkumar C, Shneider BL, Squires RH, Ranganathan S, Reyes-Mugica M, Dobrowolski SF, Mazariegos G, Elango R, Stolz DB, Strom SC, Vockley G, Roy-Chowdhury J, Cascalho M, Guha C, Sindhi R, Platt JL, Fox IJ. Host conditioning and rejection monitoring in hepatocyte transplantation in humans. J Hepatol. 2017;66(5);987-1000. 46) Heath RD, Tahan V. Allogenic adipose derived stem cells present a potential novel approach for treating refractory fistulizing Crohn’s disease. Turk J Gastroenterol 2016;27(6):568-569. 47) Heath RD, Mir F, Ibdah JA, Tahan V. Microbiome alterations observed in liver diseases present opportunities for potential fecal transplantation. Turk J Gastroenterol 2016;27(6):495-498. 48) Sathyamurthy A, Tahan V. "Are we ready to change our colorectal cancer screening practice?" Traditional serrated adenomas or serrated adenomas with dysplasia should be regarded as advanced adenomas with high grade dysplasia. Turk J Gastroenterol 2016;27(5):482-483. 49) Sathyamurthy A, Winn JN, Ibdah JA, Tahan V. Culprit for recurrent acute gastrointestinal massive bleeding: "Small bowel Dieulafoy's lesions" - a case report and literature review. World J Gastrointest Pathophysiol 2016;7(3):296-299. 50) Tahan V. Covering the Cover. Turk J Gastroenterol 2016;27:301-303. 51) Mir F, Tahan V. To chromo or not to chromo: That is the question! Turk J Gastroenterol 2016;27:403-404. 52) Winn JN, Tahan V. In a world of increasing resistance emerges a hope to eradicate Helicobacter pylori: Vonoprazan. Turk J Gastroenterol 2016;27:296-7. 53) Tahan V, Almashhrawi A, Kahveci AM, Mutrux R, Ibdah JA. Extension for Community Health Outcomes-hepatitis C: Small steps carve big footprints in the allocation of scarce resources for hepatitis C virus treatment to remote developing areas. World J Hepatol 2016;8:509-12. 54) Kahveci AS, Tahan V. Sofosbuvir and velpatasvir: a complete pan-genotypic treatment for HCV patients. Turk J Gastroenterol 2016;27:205-6. 55) Ozaras R, Tahan V, Tabak F. More on autoimmune hepatitis and acute hepatitis A. Eur J Gastroenterol Hepatol. 2016;28(3):360. 56) Kahveci AM, Tahan V. Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies. Turk J Gastroenterol 2016;27(1):89-90. 57) Tahan V, Almashhrawi A, Mutrux R, Ibdah JA. Show Me Echo – Hepatitis C: A telemedicine mentoring program for hepatitis C patients in underserved and rural areas in Missouri as a model for developing countries. Turk J Gastroenterol 2015;26:447-9. 58) Tahan AC, Tahan V. Alcohol is not safe even at Light Amounts. Balkan Med J. 2015;32(2):239. 59) Ozaras R, Tahan V, et al. Hepatic Apoptotic Markers Are Not Predictors For the Virological Response to Interferon- Based Therapy in Chronic Hepatitis C Patients. Eur J Gastroenterol Hepatol. 2015;27(9):1057-62.

Published articles in International Medical Journals (1998-2014)

60) Tahan AC, Tahan V. “If a fake friend stays in your vodkabulary as a stem friend”: Granulocyte colony-stimulating factor promoted stem cell therapy in severe alcoholic hepatitis. Turk J Gastroenterol 2014;25:748-9. 61) Tahan AC, Tahan V. Placental amniotic epithelial cells and their therapy in liver diseases. Front Med (Lausanne) 2014;1:1-4. 62) Tahan G, Tahan V. “Actions speak louder than words”: Adenoma detection rates inversely associated with colorectal cancer and mortality. Turk J Gastroenterol 2014;25:602. 63) Tahan AC, Tahan V. “Could a cup of coffee a day keep the liver doctor away?” One cup or two or more cups of coffee per day reduces the risk of death from cirrhosis. Turk J Gastroenterol 2014;25:470-1. 64) Tahan V. How will I know whether “an apple is ripe or rotten”? A new proposed composite algorithm to predict acute liver failure in patients with drug-induced liver injury. Turk J Gastroenterol 2014; 25: 347-8. 65) Tahan G, Tahan V. “Old classic cars” are hidden treasures: Colorectal cancer screening should be considered in unscreened persons over age 75. Turk J Gastroenterol 2014;25:349-50. 66) Tahan V. Once spontaneous bacterial peritonitis develops, discontinue nonselective beta blockers permanently. A proposed practice change update. Turk J Gastroenterol 2014;25:232. 67) Tahan V. Are we hopefully very close to the end of HCV? Turk J Gastroenterol 2014;25:230-1. 68) Gramignoli R, Tahan V, Dorko K, Venkataramanan R, Fox IJ, Ellis EC, Vosough M, Strom SC. Rapid-and-Sensitive Assessment of Human Hepatocyte Functions. Cell Transplant 2014;23:1545- 56. (This article clearly released all of the most efficient technics’ information in a reader-friendly manner by my UPMC Team). 69) Gramignoli R, Dorko K, Tahan V, Skvorak KJ, Ellis E, Jorns C, Ericzon BG, Fox IJ, Strom SC. Hypothermic storage of human hepatocytes for transplantation. Cell Transplant 2014;23:1143-51. 70) Gramignoli R, Tahan V, Dorko K, Skvorak KJ, Hansel MC, Zhao W, Venkataramanan R, Ellis EC, Jorns C, Ericzon BG, Rosenborg S, Kuiper R, Soltys KA, Mazariegos GV, Fox IJ, Wilson EM, Grompe M, Strom SC. New potential cell source for hepatocyte transplantation: discarded livers from metabolic disease liver transplants. Stem Cell Res. 2013;11(1):563-73. 71) Skvorak KJ, Dorko K, Marongiu F, Tahan V, Hansel MC, Gramignoli R, Arning E, Bottiglieri T, Gibson KM, Strom SC. Improved amino acid, bioenergetic metabolite and neurotransmitter profiles following human amnion epithelial cell transplant in intermediate maple syrup urine disease mice. Mol Genet Metab. 2013;109(2):132-8. 72) Hansel MC, Gramignoli R, Blake W, Davila J, Skvorak K, Dorko K, Tahan V, Lee BR, Tafaleng E, Guzman-Lepe J, Soto-Gutierrez A, Fox IJ, Strom SC. Increased Reprogramming of Human Fetal Hepatocytes Compared With Adult Hepatocytes in Feeder-Free Conditions. Cell Transplant 2014 Jan;23(1):27-38. 73) Skvorak KJ, Dorko K, Marongiu F, Tahan V, Hansel MC, Gramignoli R, Gibson KM, Strom SC. Placental stem cell correction of murine intermediate maple syrup urine disease. Hepatology 2013 Mar;57(3):1017-23. (This article has shown the most efficient amniotic epithelial stem cell treatment for maple syrup disease invivo by my UPMC Team). 74) Sharma S, Ellis EC, Gramignoli R, Dorko K, Tahan V, Hansel M, Mattison DR, Caritis SN, Hines RN, Venkataramanan R, Strom SC. Hepatobiliary Disposition of 17-OHPC and Taurocholate in Fetal Human Hepatocytes: A Comparison with Adult Human Hepatocytes. Drug Metab Dispos 2013;41:296-304. 75) Uraz S, Tahan G, Aytekin H, Tahan V. N-acetylcysteine expresses powerful anti-inflammatory and antioxidant activities resulting in complete improvement of acetic acid-induced colitis in rats. Scand J Clin Lab Invest 2013;73:61-6. 76) Gramignoli R, Green ML, Tahan V, Dorko K, Skvorak KJ, Marongiu F, Zao W, Venkataramanan R, Ellis EC, Geller D, Breite AG, Dwulet FE, McCarthy RC, Strom SC. Development and application of purified tissue dissociation enzyme mixtures for human hepatocyte isolation. Cell Transplant 2012;21:1245-60. 77) Tahan G, Aytac E, Aytekin H, Gunduz F, Dogusoy G, Aydin S, Tahan V, Uzun H. Vitamin E has a dual effect of anti- inflammatory and antioxidant activities in acetic acid-induced ulcerative colitis in rats. Can J Surg 2011;54:333-8. 78) Tarcin O, Basaranoglu M, Tahan V, Tahan G, Sücüllü I, Yilmaz N, Sood G, Snyder N, Hilman G, Celikel C, Tözün N. Time course of collagen peak in bile duct-ligated rats. BMC Gastroenterol. 2011 Apr 28;11:45. 79) Marongiu F, Gramignoli R, Dorko K, Miki T, Ranade AR, Paola Serra M, Doratiotto S, Sini M, Sharma S, Mitamura K, Sellaro TL, Tahan V, Skvorak KJ, Ellis EC, Badylak SF, Davila JC, Hines R, Laconi E, Strom SC. Hepatic differentiation of amniotic epithelial cells. Hepatology 2011 May;53(5):1719-29. (This article has shown the most efficient amniotic epithelial stem cell transformation into a hepatocytel like cell in vitro by my UPMC Team). 80) Akin H, Tahan G, Türe F, Eren F, Atuğ O, Tahan V, Hamzaoğlu I, Imeryüz N, Tözün N, Hamzaoglu HO. Association between bactericidal/permeability increasing protein (BPI) gene polymorphism (Lys216Glu) and inflammatory bowel disease. J Crohns Colitis 2011;5:14-8. 81) Tahan G, Eren F, Tarçin O, Akin H, Tahan V, Şahın H, Özdoğan O, İmeryüz N, Çelıkel Ç, Avşar E, Tözün N. Effects of a long-acting somatostatin analogue, lanreotide, on bile duct ligation-induced liver fibrosis in rats. Turk J Gastroenterol 2010;21:287-92. 82) Tahan G, Gramignoli R, Marongiu F, Aktolga S, Cetinkaya A, Tahan V, Dorko K. Melatonin expresses powerful anti- inflammatory and antioxidant activities resulting in complete improvement of acetic-acid-induced colitis in rats. Dig Dis Sci 2011;56:715-20. 83) Senturk H, Baysal B, Tahan V, Zerdali H, Ozaras R, Tabak F, Mert A, Canbakan B, Tabak O, Ozbay G. Long-term effect of interferon therapy in patients with HBeAg positive chronic hepatitis B infection. Dig Dis Sci 2011;56:208-12. 84) Tahan G, Eren F, Tarcin O, Akin H, Tahan V, Sahin H, Ozdogan O, Imeryuz N, Celikel C, Avsar E, Tozun T. Effects of a long-actıng somatostatın analogue, lanreotıde on bile-duct ligation induced liver fibrosis in rats. Turk J Gastroenterol 2010;21:287-292. 85) Tahan G, Akin H, Aydogan F, Tarcin O, Ramadan S, Yapicier O, Uzun H, Tahan V, Zengin K. Melatonin ameliorates bile duct ligation-induced liver fibrosis in rats. Can J Surg 2010;53:313-318. 86) Ozdemir FT, Tiftikci A, Sancak S, Eren F, Tahan V, Akin H, Gunduz F, Kedrah AE, Ustundag Y, Avsar E, Tozun N, Ozdogan O. The Prevalence of the Mutation in Codon 249 of the P53 Gene in Patients with Hepatocellular Carcinoma (HCC) in Turkey. J Gastrointest Canc 2010;41:185-189. 87) Marongiu F, Gramignoli R, Miki T, Sun Q, Tahan V, Dorko K, Ellis E, Strom S. Isolation of Amniotic Mesenchymal Stem Cells. Curr Protoc Stem Cell Biol 2010 Mar;Chapter 1:Unit 1E.5. 88) Tahan V, Ozaras R, Karaca C, Uraz S, Eren F, Tozun N. Is HCV Genotyping Cost-effective Even When the Prevalence of Genotypes 2 and 3 are Low? Hepatogastroenterology 2009;56:1425-8. 89) Canbakan B, Akin H, Tahan G, Tarcin O, Eren F, Atug O, Tahan V, Imeryuz N, Yapicier O, Avsar E, Tozun N. The effects of pegylated interferon alpha 2b on bile-duct ligation induced liver fibrosis in rats. Ann Hepatol 2009;8:234-40. 90) Akbas T, Duman D, Tahan V, Barghi I, Tozun N. Aorto-enteric fistula: a dilemma for the endoscopist as a rare cause of gastro-intestinal Bleeding. Acta Chir Belg 2009;109:541-3. 91) Tahan V, Atug O, Akin H, Eren F, Tahan G, Tarcin O, Uzun H, Ozdogan O, Tarcin O, Imeryuz N, Ozguner F, Celikel C, Avsar E, Tozun N. Melatonin ameliorates methionine choline deficient diet induced nonalcoholic steatohepatitis in rats. J Pineal Res 2009;46:401-407. 92) Ozaras R, Tahan V. Acute hepatitis C: prevention and treatment. Expert Rev Anti Infect Ther 2009;7:351-61. 93) Atug O, Tahan V, Eren F, Tiftikci A, Imeryuz N, Hamzaoglu HO, Tozun N. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPARgamma) gene in inflammatory bowel disease. J Gastrointestin Liver Dis 2008;17:433-7. 94) Tahan V, Sayrak H, Bayar N, Erer B, Tahan G, Dane F. Doxycycline-induced ulceration mimicking esophageal cancer. Cases J 2008;1:144. 95) Tahan V, Canbakan B, Senturk H, Olgac V, Balci H, Sut N, Hatemi I. Serum Gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk. Hepatogastroenterology 2008;55:1433-8. 96) Ozaras R, Ipekci S, Kumbasar H, Aybar Y, Tahan V, Mert A, Ozturk R, Tabak F. Does the presence of peripheral and intraabdominal lymphadenopathy predict the etiology of acute hepatitis? J Clin Gastroenterol 2009;43:196. 97) Tabak F, Ozdemir F, Tabak O, Erer B, Tahan V, Ozaras R. Autoimmune hepatitis induced by the prolonged hepatitis A virus infection. Ann Hepatol 2008;7:177-179. 98) Ozaras R, Tabak F, Tahan V, Ozturk R, Akin H, Mert A, Senturk H. Correlation of Quantitative Assay of HBsAg and HBV DNA Levels During Chronic HBV Treatment. Dig Dis Sci 2008;53:2995-8. 99) Tabak F, Gunduz F, Tahan V, Tabak O, Ozaras R. Sertraline Hepatotoxicity: Report of a Case and Review of the Literature. Dig Dis Sci 2009;54:1589-91. 100) Canbakan B, Tahan V, Balci H, Hatemi I, Erer B, Ozbay G, Sut N, Hacibekiroglu M, Imeryuz N, Senturk H. Leptin in nonalcoholic fatty liver disease. Ann Hepatol 2008;7:249-54. 101) Ozaras R, Yilmaz M, Mete B, Demirel A, Tahan V. Recognizing Acute Hepatitis C in Hemodialysis Patients. Dig Dis Sci 2008;53:3267-8. 102) Senturk H, Tahan V, Canbakan B, Uraz S, Ulger Y, Ozaras R, Tabak F, Mert A, Ozbay G. Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers. Neth J Med 2008;66:20-24. 103) Tarcin O, Gedik N, Karakoyun B, Tahan V, Pocan S, Celikel C, Isguzar S, Tozun N. Serum prolidase and IGF-1 as non-invasive markers of hepatic fibrosis during four different periods following bile-duct ligation in rats. Dig Dis Sci 2008;53:1938-1945. 104) Senturk H, Tahan V, Canbakan B, Dane F, Ulger Y, Ozaras R, Tabak F, Mert A, Ozbay G. Clinicopathologic features of dual chronic hepatitis B and C infection: a comparison with single hepatitis b, c and delta infections. Ann Hepatol 2008;7:52-58. 105) Uraz S, Tahan V, Aygun C, Eren F, Unluguzel G, Yuksel M, Senturk O, Avsar E, Haklar G, Celikel C, Hulagu S, Tozun N. Role of ursodeoxycholic acid in prevention of methotrexate induced liver toxicity. Dig Dis Sci 2008;53:1071-7. 106) Ozdodan O, Atalay H, Cimsit C, Tahan V, Baltacioglu F, Tuney D, Giral A, Imeryuz N, Tokay S, Erzen C, Tozun N. The role of echo doppler ultrasonography for the evaluation of postprandial hyperemia in cirrhotic patients. World J Gastroenterol 2008;14:260-4. 107) Atug O, Hamzaoglu H, Tahan V, Alican I, Kurtkaya O, Elbuken E, Ozdogan O, Tozun N. Hyperbaric oxygen therapy is as effective as dexamethasone in the treatment of TNBS-E induced experimental colitis. Dig Dis Sci 2008;53:481-5. 108) Tahan V, Imeryuz N, Avsar E, Celikel C, Tozun N. Effects of rosiglitazone on methionine- choline deficient diet induced non-alcoholic steatohepatitis. Hepatology 2007;46:2045. 109) Imeryuz N, Tahan V, Sonsuz A, Eren F, Uraz S, Yuksel M, Akpulat S, Ozcelik D, Haklar G, Celikel C, Avsar E, Tozun N. Iron preloading aggravates nutritional steatohepatitis in rats by increasing apoptotic cell death. J Hepatol 2007;47:851-859. (This article has been first in the field to prove the effect of iron on direct fibrosis in NASH). 110) Akin H, Deniz M, Can G, Celikel C, Yegen B, Kedrah AE, Tahan V, Tozun N, Imeryuz N. High-fat Liquid 'Lieber-DeCarli' Diet for an Animal Model of Non-Alcoholic Steatohepatitis. Does It really work? Hepatol Int 2007;1:449-450. 111) Canbakan B, Senturk H, Tahan V, Hatemi I, Balci H, Toptas T, Sonsuz A, Velet M, Aydin S, Dirican A, Ozgulle S, Ozbay G. Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease. Acta Gastroenterol Belg 2007;70:277-284. 112) Tahan V, Tahan G, Dane F, Uraz S, Yardim M. Acute pancreatitis attributed to the use of pegylated interferon in a patient with chronic hepatitis C. J Gastrointestin Liver Dis 2007;16:224. 113) Ozdogan O, Tahan V, Cincin A, Imeryuz N, Tozun N. Acute pancreatitis associated with the use of peginterferon. Pancreas 2007;34:485-7. 114) Tahan G, Tarcin O, Tahan V, Eren F, Gedik N, Sahan E, Biberoglu N, Guzel S, Bozbas A, Tozun N, Yucel O. The Effects of N-Acetylcysteine on Bile Duct Ligation-Induced Liver Fibrosis in Rats. Dig Dis Sci 2007;52:3348-3354. 115) Tahan V, Eren F, Avsar E, Yavuz D, Yuksel M, Emekli E, Imeryuz N, Celikel C, Uzun H, Haklar G, Tozun N. Rosiglitazone Attenuates Liver Inflammation in a Rat Model of Nonalcoholic Steatohepatitis. Dig Dis Sci 2007;52:3465- 3472. 116) Eren F, Tahan V, Ozdemir F, Akin H, Tozun N. Peptide nucleic acids for the detection of YMDD in chronic hepatitis B. J Gastrointestin Liver Dis 2006;15:320-1. 117) Tahan V, Akpinar I, Imeryuz N, Tozun N. Asymptomatic achalasia mimicking mediastinal mass. J Gastrointestin Liver Dis 2006;15:203-4. 118) Canbakan B, Senturk H, Tabak F, Akdogan M, Tahan V, Mert A, Sut N, Ozaras R, Midilli K, Ozbay G. Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: A randomized trial. J Gastroenterol Hepatol 2006;21:657-63. 119) Yildirim B, Tahan V, Ozaras R, Aytekin H, Mert A, Tabak F, Senturk H. Hepatitis C virus risk factors in the Turkish community. Dig Dis Sci 2005;50:2352-5. 120) Tahan V, Karaca C, Yildirim B, Bozbas A, Ozaras R, Demir K, Avsar E, Mert A, Besisik F, Kaymakoglu S, Senturk H, Cakaloglu Y, Kalayci C, Okten A, Tozun N. Sexual transmission of HCV between spouses. Am J Gastroenterol 2005;100:821-4. (This article got Editorial Citation in the same volume and cited by REUTERS and multiple Media). 121) Tahan V, Ozaras R, Lacevic N, Ozden E, Yemisen M, Ozdogan O, Mert A, Tabak F, Avsar E, Celikel CA, Ozbay G, Kalayci C, Senturk H, Tozun N. Prevalence of hepatic granulomas in chronic hepatitis B. Dig Dis Sci 2004;49:1575- 7. 122) Tahan V, Yavuz D, Imeryuz N, Avsar E, Tozun N. Oral glucose tolerance deteriorates in rats fed with methionine choline deficient diet. J Hepatol 2004;41:352. 123) Tahan V, Ozaras R, Canbakan B, Uzun H, Aydin S, Yildirim B, Aytekin H, Ozbay G, Mert A, Senturk H. Melatonin reduces dimethylnitrosamine-induced liver fibrosis in rats. J Pineal Res 2004;37:78-84. 124) Tahan V, Yildirim B, Ture F, Giral A, Ozdogan O, Imeryuz N, Avsar E, Mert A, Senturk H, Kalayci C, Tozun N. Anti-HCV Seroprevalence in chronic HCV patient’s children in Turkey. J Clin Gastroenterol 2004;38:90-1. 125) Ozaras R, Tahan V, Mert A, Uraz S, Kanat M, Tabak F, Avsar E, Ozbay G, Celikel CA, Tozun N, Senturk H. The prevalence of hepatic granulomas in chronic hepatitis C. J Clin Gastroenterol 2004;38:449-52. 126) Tahan V, Ozdogan O, Tozun N. Epidemiology of viral hepatitis in the Mediterranean Basin. Rocz Akad Med Bialymst 2003;48:11-7. 127) Tahan V, Avsar E, Karaca C, Uslu E, Eren F, Aydin S, Uzun H, Hamzaoglu HO, Besisik F, Kalayci C, Okten A, Tozun N. Adrenomedullin in cirrhotic and non-cirrhotic portal hypertension. World J Gastroenterol 2003 Oct;9(10):2325- 7. 128) Tahan V, Ozseker F, Guneylioglu D, Baran A Ozaras R, Mert A, Ucisik AC, Cagatay T, Yilmazbayhan D, Senturk H. Sarcoidosis After The Use of Interferon for Chronic Hepatitis C: Report of a Case and Review of the Literature. Dig Dis Sci 2003 Jan(48):169-173. 129) Ozaras R, Tahan V, Aydin S, Uzun H, Kaya S, Senturk H. N-acetyl cysteine attenuates alcohol-induced oxidative stress in the rat. World J Gastroenterol 2003 Jan;9(1):125-8. 130) Ozaras R, Mert A, Tahan V, Uraz S, Ozaydin I, Yilmaz MH, Ozaras N. Ciprofloxacin and Achilles' tendon rupture: a causal relationship. Clin Rheumatol 2003 Dec;22(6):500-1. 131) Goksugur N, Ozaras R, Tahan V, Mert A, Soysal T, Aydemir E, Tabak F. Toxic shock syndrome due to Staphylococcus aureus sepsis following diagnostic laparotomy for Hodgkin's disease. J Eur Acad Dermatol Venereol 2003 Nov;17(6):732-3. 132) Ozaras R, Yilmaz MH, Tahan V, Uraz S, Yigitbasi R, Senturk H. Spontaneous hematoma of the rectus abdominis muscle: a rare cause of acute abdominal pain in the elderly. Acta Chir Belg 2003;103(3):332-3. 133) Aydin S, Ozaras R, Uzun H, Belce A, Uslu E, Tahan V, Altug T, Dumen E, Senturk H. N-acetylcysteine reduced the effect of ethanol on antioxidant system in rat plasma and brain tissue. Tohoku J Exp Med 2002 Oct;198(2):71-7. 134) Mert A, Tabak F, Ozaras R, Tahan V, Ozturk R, Aktuglu Y. Tuberculous lymphadenopathy in adults: a review of 35 cases. Acta Chir Belg 2002 Apr;102(2):118-21. 135) Altiparmak MR, Ataman R, Ozaras R, Tahan V, Aydin S, Uzun H, Serdengecti K, Soysal T. Relative erythrocytosis of patients with end stage renal failure undergoing CAPD. Ren Fail 2002;24(1):29-35. 136) Mert A, Tabak F, Ozaras R, Tahan V, Senturk H, Ozbay G. Hepatic granulomas in chronic hepatitis C. J Clin Gastroenterol 2001 Oct;33(4):342-3. 137) Tahan V, Ozaras R, Uzunismail H, Mert A, Tabak F, Ozturk R, Aktuglu Y, Ozbay G. Infectious mononucleosis presenting with severe cholestatic liver disease in the elderly. J Clin Gastroenterol 2001 Jul;33(1):88-9. 138) Tahan V, Dobrucali A, Canbakan B, Hamzaoglu I, Ozaras R, Biyikli M, Dogusoy G, Mert A, Furth EE. Cytomegalovirus infection of gastrointestinal tract with multiple ulcers and strictures, causing obstruction in a patient with common variable immunodeficiency syndrome. Dig Dis Sci 2000 Sep;45(9):1781-5. 139) Mert A, Ozaras R, Bilir M, Tahan V, Cetinkaya A, Yirmibescik S, Ozbay G, Senturk H. The Etiology of Hepatic Granulomas. J Clin Gastroenterol 2001 Mar;32(3):275-276. 140) Ozaras R, Tahan V, Turkmen S, Talay F, Besirli K, Aydin S, Uzun H, Cetinkaya A. Changes in malondialdehyde levels in bronchoalveolar fluid and serum by the treatment of asthma with inhaled steroid and beta2-agonist. Respirology 2000 Sep;5(3):289-92. 141) Mert A, Ozaras R, Bilir M, Cicek Y, Tabak F, Tahan V, Ozturk R. Primary Tuberculosis of the Parotid Gland. Int J Infect Dis 2000;4(4):229-230. 142) Bilir M, Mert A, Ozaras R, Yanardag H, Karayel T, Senturk H, Tahan V, Ozbay G, Sonsuz A. Hepatic sarcoidosis: clinicopathologic features in thirty-seven patients. J Clin Gastroenterol 2000 Dec;31(4):337-8 143) Turkmen S, Uzun H, Aydin S, Ozaras R, Tahan V, Oztekin GE, Dondurmaci S. Increased urinary NAG excretion in hypertensives can decline with antihypertensive treatment. Nephron 2000 Oct;86(2):225-6. 144) Yildirim B, Ozaras R, Tahan V, Artis T. Diaphragmatic Morgagni hernia in adulthood: correct preoperative diagnosis is possible with newer imaging techniques. Acta Chir Belg 2000 Feb;100(1):31-3. 145) Mert A, Bilir M, Ozturk R, Tabak F, Ozaras R, Tahan V, Senturk H, Aktuglu Y. Tuberculous subcutaneous abscesses developing during miliary tuberculosis therapy. Scand J Infect Dis 2000;32(1):37-40. 146) Kaya H, Oral B, Ozguner F, Tahan V, Babar Y, Delibas N. The effect of melatonin application on lipid peroxidation during cyclophosphamide therapy in female rats. Zentralbl Gynakol 1999;121(10):499-502. 147) Ozguroglu M, Tahan V, Ozguroglu E, Ozaras R, Demir G. Paraneoplastic hyper pigmentation secondary to lung cancer resolving after chemotherapy. Am J Clin Oncol 1999 Oct;22(5):533-4. 148) Ozguroglu M, Ozaras R, Tahan V, Demirkesen C, Demir G, Dogusoy G, Buyukunal E, Serdengecti S, Berkarda B. Anorectal melanoma metastatic to the breast. J Clin Gastroenterol 1999 Sep;29(2):197-9. 149) Apaydin S, Ozaras R, Erek E, Tahan V, Altiparmak MR, Celik Y, Cetinkaya A. Chlorambucil-induced seizure in a patient with nephrotic syndrome. Nephron 1999;82(4):368. 150) Mert A, Ozaras R, Tabak F, Tahan V, Akdogan M, Senturk H. Spouses of HCV carriers are not at serious risk. Scand J Infect Dis 1998;30(6):644. (This study was the first in the literature stating that chronic HCV patients’ spouses were not at serious risk of HCV transmission. During those years divorse was common if one spouse was HCV infected. This observcation changed our management and started even not to recommend condom use between devoted relations). 151) Ozcankaya R, Delibas N, Ozguner F, Tahan V, Acar A. Cortisol and thyroid hormones in patients with depression and Dinar Earthquake induced PTSD. Mater Med Pol 1998;31(3-4):20-4.

Published Medical Articles in Turkey 1) Tahan V. Karaciğer yağlanması: Gelişen toplumun yeni sorunu mu? Nabız 2008; 5(20): 46-49. 2) Tahan V, Ozaras R, Karaca Ç, Eren F, Danalıoğlu A, Uraz S, Avşar E, Türkoğlu S, Midilli K, Tabak F, Öztürk R, Mert A, Tözün N, Şentürk H. Is HCV genotyping cost-effective even when the prevalence of genotypes 2 and 3 are low? Cerrahpaşa Medical Review 2007;5:23-26. 3) Tözün N, Duman D, Tahan V. İnflamatuar barsak hastalığı ve malnutrisyon, ilaç-gıda etkileşimleri. V. Uluslararası beslenme ve diyetetik kongresi. Kongre Kitabı. 12-15 Nisan 2006;p106-110. English - Tözün N, Duman D, Tahan V. Inflammatory bowel disease and malnutrition; drug and nutrient interactions. V. International nutrition and dietetics Congress. Congress Proceedings. 12-15 April 2006; p110-114. 4) Tahan V. Karaciğer Granulomları. Gastrolife 2005;4:1-7. 5) Tahan V, Ataizi Çelikel, Özdoğan O. Nonalkolik Steatohepatit. Aktüel Tıp Dergisi 2004;9:33-37. 6) Gençosmanoğlu R, Tahan V, Kurtkaya-Yapıcıer Ö. Safra kesesi kanseri: Etyopatogenez, tanı yöntemleri, evreleme, tedavi modaliteleri ve prognoza güncel bakış. Güncel Gastroenteroloji 2003;7:157-169. 7) Tahan V, Tözün N. İnflamatuar barsak hastalığı ve nütrisyon. Turk J Gastroenterol 2002;13 (Suppl 1):5-8. 8) Demirci M, Yorgancıgil B, Tahan V, Arda M. Isparta yöresinde kene ısırığı olanlarda Lyme Hastalığı seropozitifliği. İnfeksiyon Dergisi (Turkish Journal of Infection) 2001;15:17-20. 9) Tüfekçi BI, Tahan V, Mat A. Bir mantar zehirlenmesi olgusu: Pantherina Sendromu. Klinik Gelişim 2000;13:249-251. 10) Bilir M, Mert A, Özaras R, Tahan V, Tabak F, Öztürk R, Özbay G, Şentürk H, Aktuğlu Y. Lokalize hepatik tüberküloz: Bir olgu sunumu ve literatür derlemesi. Klimik Dergisi 2000;3:30-32. 11) Mert A, Bilir M, Özaras R, Tahan V, Çetinkaya A, Yirmibeşcik S, Tabak F, Öztürk R, Aktuğlu Y, Özbay G, Şentürk H. Hepatik granulomların etyolojisinde sarkoidoz ve tüberkülozun yeri: 56 olgunun geriye dönük değerlendirilmesi ve literatür derlemesi. Flora 2000;5:258-263. 12) Şahin Ü, Tahan V, Akkaya A, Ünlü M, Sekreter M. Primer akciğer kanserinde lipid peroksidasyonu ve eritrosit antioksidan enzim aktivitesi. Tüberküloz ve Toraks Dergisi 1999;47:31-35. 13) Mert A, Bilir M, Öztürk R, Tabak F, Özaras R, Tahan V, Aktuğlu Y. Tedavi sırasında dev boyutlarda paradoksal deri altı tüberküloz apseleri gelişen bir milier tüberküloz olgusu. Klinik Gelişim 1999;12:837-840. 14) Özgüner MF, Delinaş N, Tahan V, Koyu A, Köylü H. Effects of industrial noise on the blood levels of superoxide dismutase, glutathione peroxidase and malondialdehide. Eastern Journal of Medicine 1999;4:13-15. 15) Özgüroğlu M, Pazarlı H, Özaras R, Demir G, Tahan V, Demirelli F, Mandel NM, Büyükünal E, Serdengeçti S, Berkarda B. Uveal malign melanomlu olguların retrospektif değerlendirilmesi - tedavi yaklaşımları ve sonuçları. Avicena Dergisi 1999;1:30-32. 16) Özgüroğlu M, Tahan V, Özaras R, Demir G, Çerçel A, Demirelli F, Mandel NM, Büyükünal E, Serdengeçti S, Berkarda B, Çelik V. Kadınlarda primeri bilinmeyen aksiller karsinom metasıtazına yaklaşım: İki olgu bildirimi. Meme Hastalıkları Dergisi 1998;5:172-174. 17) Ünlü M, Tahan V, Akkaya A, Demirci M, Şahin Ü. Erişkin sigara içenlerde plazma lipid peroksidasyonu. Tıp Bilimleri Dergisi 1998;18:105-108. 18) Kaya H, Aydın G, Çetin M, Mandal T, Babar Y, Tahan V, Başaran Sarı A. Bilateral multikistik renal displazi ve bilateral üreteral obstrüksiyon. T Klin Med Sci 1998;18:203-207. 19) Nazıroğlu M, Çay M, Tahan V, Bal R, Delibaş N. Effects of selenium and vitamin E supplementation on concentrations of plasma thyroid hormones in lambs. Tr. J. Of Veterinary and Animal Sciences 1998;22:157-160. 20) Özgüner MF, Serel TA, Delinaş N, Tahan V, Koyu A, Çalışkan S, Köylü H. The effect of melatonin on shock wave induced renal damage. Eastern Journal of Medicine 1998;3:48-50. 21) Durmuş M, Bardak Y, Delibaş N, Tahan V. Senil katarakt patogenezinde serbest radikal hasarı ve lipid peroksidasyonunun rolü. Türk Oftalmoloji Gazetesi 1998;28:14-17. 22) Tahan V, Ünlü M, Delibaş N. Sigara dumanına maruz bırakılan tavşanlarda kan lipid düzeylerindeki değişiklikler. Yeni Tıp Dergisi 1997;14:342-343. 23) Döner F, Tahan V, Delibaş N, Doğru H, Kılıçkaya M. Baş-boyun tümörlerinde malondialdehid düzeyleri. THOD 1997;2:85-88. 24) Delibaş N, Özcankaya R, Özgüner F, Tahan V, Mumcu N, Acar A. Bilişsel durum değişimleri ile kan lipid, lipoprotein ve apolipoprotein düzeylerinin ilişkisi. Yeni Symposium 1996;34:10-14. 25) Delibaş N, Aydemir M, Ayata A, Demirci M, Tahan V. Giardiazisli çocuklarda Fe, Cu, Zn düzeyleri ve eritrosit SOD aktivitesi. Türkiye Parazitoloji Dergisi 1996;20:25-29. 26) Gedikli O, Delibaş N, Doğru H, Döner F, Arslan A, Tahan V, Erdoğan Y. Kronik böbrek yetmezliğinde işitme kaybı ve antioksidanlar. Kulak Burun Boğaz İhtisas Dergisi 1996;3:594-599. 27) Kaya H, Akdoğan M, Acar A, Tahan V, Mandal T, Babar Y. Hirşutizmde insüline rezistans ve lipid düzeyi değişiklikleri. SDÜ Tıp Fakültesi Dergisi 1996;3:43-46. 28) Kaya H, Delibaş N, Çapar M, Tahan V, Serteser M, Özkaya MO. Gebelikte ve postpartum erken dönemde serbest radikal oluşumu ve antioksidan enzim düzeyleri. SDÜ Tıp Fakültesi Dergisi 1996;3:67-70. 29) Kaya H, Delibaş N, Babar Y, Serteser M, Tahan V, Arı FF. Gebelikte demir tedavisiyle serbest radikal oluşumu ve antioksidan tedaviyle karşılanması. SDÜ Tıp Fakültesi Dergisi 1996;3:59-63. 30) Delibaş N, Doğru H, Döner F, Gedikli O, Tahan V. Presbiakuzi ve serbest radikaller. K.B.B. ve Baş Boyun Cerrahisi Dergisi 1996; 4: 8-11. 31) Şahin Ü, Döner F, Koşar A, Arslan A, Tahan V. Streptomisine bağlı ototoksisite ve nefrotoksisite. SDÜ TıpFakültesi Dergisi 1996; 3: 87-89. 32) Tunç B, Delibaş N, Akhan G, Tahan V, Örmeci AR. Thyroid functions in children with cerebral palsy and effects of phenobarbital on thyroid hormones. SDÜ Tıp Fakültesi Dergisi 1995; 2: 9-13. 33) Tunç B, Akdoğan M, Tahan V. Yenidoğan hiperbilirubinemi tedavisinde E vitamininin rolü. Yeni Tıp Dergisi 1995; 12: 398-400. 34) Delibaş N, Tahan V. Lipoprotein metabolizması ve ateroskleroz ile ilişkisi. SDÜ Tıp Fakültesi Dergisi 1995; 2: 39-44. 35) Delibaş N, Gedikli O, Doğru H, Tahan V. Gürültüye bağlı işitme kaybında serum lipid düzeyleri. SDÜ Tıp Fakültesi Dergisi 1995; 2: 43-47. 36) Tunc B, Akdogan M, Serel TA, Aydemir M, Yorgancigil Birdal, Tahan V. The prevalence of asymptomatic pyuria and bacteriuria in primary school children. SDÜ Tıp Fakültesi Dergisi 1995; 2: 21-24.

INVITED LECTURES, SEMINARS, AND SYMPOSIUM TALKS 1) “Cell therapies for liver diseases” Grand Round Presentation, University of Missouri, Grand May 23, 2017 Rounds 12:00pm–1:00pm. Columbia, MO 2) “ECHO- HCV Project” 32nd National Gastroenterology Week. Titanic Deluxe Hotel. Belek, November 27, 2015 Antalya, Turkey. 3) “Medical Specialty; why and how?” Akdeniz University Faculty of Medicine, Antalya, Turkey. November 25, 2015 4) “ECHO- HCV Project” Akdeniz University Faculty of Medicine, Antalya, Turkey. November 25, 2015 5) “Stem cells and hepatocyte transplantation” 24th Conference of Asian-Pacific Association for March 13, 2015 The study of the liver (APASL). Time: 13:15-14:45. APASL 12-15 March 2015 / Istanbul Turkiye. 6) “Cell transplantation for liver diseases”. East Carolina University, Department of GI. Time: May 29, 2014 12:00-01:00 pm. 521 Moye Medical Center Greenville, NC, USA. 7) “Cell transplantation in liver diseases”. The University of Texas Health GHN Clinical Grand February 20, 2014 Rounds, Time 8:00-9:00 am, Location: UT MSB- B.100. Houston, TX, USA. 8) “Does my partner have HCV? & Is iron bad for NAFLD?” The University of Iowa Hospitals and November 7, 2013 Clinics, Gastroenterology Grand Rounds, Time: 17:00- 18:00 pm, Location: UIHC- Ziffren Auditorium, Iowa City, IA, USA. 9) “Cell Therapy” The University of Iowa Hospitals and Clinics, Gastroenterology Grand Rounds, November 8, 2012 Time: 17:00- 18:00 pm, Location: UIHC- Ziffren Auditorium, Iowa City, IA, USA. 10) “Stem Cell Therapy - Kok Hucre Tedavisi” 4. Hepatoloji Okulu, Hilton Oteli, Bodrum, Mugla, May 26, 2012 Turkey. 11) “Liver Granulomas” 6th Hepatogastroenterology Congress. Gloria Resort Hotel, Antalya, September 2009 Turkey. 12) “Sexual transmission of HCV; who should be protected and how?” Turkish Society of Liver Junuary 11, 2008 Researches. Hepatitis C Update Meeting. The Marmara Hotel, Istanbul, Turkey. 13) “Pathogenesis and genetic factors of NASH”. Turkish Society of Liver Studies Meeting. Istanbul, April 18, 2007 Turkey. 14) “Pathogenesis of nonalcoholic steatohepatitis”. ARiS. Feriye Lokantası, Istanbul, Turkey. December 11, 2007 15) “Experimental Hepatology: NASH models”. 6th National Hepatology Congress. June 10, 2007 16) “Rare causes of upper gastrointestinal bleeding”. Turkish Society of Internal Medicine. Derneği. February 2, 2006 Istanbul University Medical Faculty, Kemay Atay Amplifier, Istanbul, Turkey. 17) “Is liver biopsy obligatory for NASH?” 1st Hepatology School. Debates in liver diseases. June 22-25, 2006 Cappadocia Lodge Country Clup, Nevşehir, Turkey. 18) “From symptom to diagnosis” Approach to the patient with dyspepsia”. Turkish Society of May 5, 2005 Internal Medicine. Istanbul University Medical Faculty, Kemay Atay Amplifier, Istanbul, Turkey. 19) “Experimental fatty liver disease models”. 1st Erciyes Clinical and Experimental May 19-22, 2004 Gastroenterology Days. Kayseri, Turkey. 20) “Fatty Liver and nonalcoholic steatohepatitis experimental models”. Turkish Society of Internal January 15, 2004 Medicine, Marmara University School of Medicine, Istanbul, Turkey.

POSTER/ORAL PRESENTATIONS National/International Conference Presentations

American College of Gastroenterology (ACG) 2020 Virtual. October 23- 28, 2020. 1) Rossow B, Tahan V, Samiullah S, Hammoud GM. Predictors of Surgical Intervention in Patients Who Underwent Endoscopic Therapy for Symptomatic Walled-Off Pancreatic Necrosis Using Lumen-Apposing Metal Stents: A Single Center Case Series. S3083; The American Journal of Gastroenterology. 115:S1625, October 2020. 2) Harleen C, Dahip M, Basar O, Tahan V, Daglilar E. A Wrench in time. S2062. The American Journal of Gastroenterology. 115:S1083, October 2020. 3) Tarar ZI, Tahan V, Yin F, Daglilar E, Basar O, Yin F. A rare case of hyperplastic polyp of esophagus on a Schatzki’s ring. S1936. The American Journal of Gastroenterology: October 2020 - Volume 115 - Issue - p S1008.

Digestive Disease Week® (DDW) 2020 at at McCormick Place Chicago, IL May 2-5, 2020. Virtual. . 4) Pasha AS, Ghouri Y, Tahan V. A comperision of lymphocytic colitis and collagenous colitis (3355560).

American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 2019 at Hynes Convention Center in Boston, MA, November 8-12, 2019. 5) Ali AH, Panchal S, Chen D, Gan Y, Deepthi RA, Al-Juboori A, Samiullah S, Mahdi A, Tahan V, Ibdah JA, Hammoud GH. The efficacy and safety of endoscopic ultrasound-guide liver biopsy versus percutaneous liver biopsy in patients with chronic liver disease, a retrospective single center study. Publication # 0644.

American College of Gastroenterology (ACG) 2019 at Henry B. Gonzalez Convention Center in San Antonio, Texas, October 25- 30, 2019 1) Dave I, Dailey F, Turse E, Tahan V. An unusual cuse of abdominal pain and elevated liver chemistries. P3185. The American Journal of Gastroenterology. 114:S1703, October 2019. 2) Turse E, Dailey F, Tahan V. The impact of multitarget stool DNA (Cologuard) testing in a real world population. P2848. The American Journal of Gastroenterology. 114:S1565, October 2019. 3) Pasha SB, Ghouri Y, Tahan V. Pseudomelanosis of stomach and duodenum. P3119. The American Journal of Gastroenterology. 114:S1677-S1678, October 2019. 4) Suha Abu Khalaf, MD, Abdulmajeed Albarrak, MD, Mohamad Yousef, MD, Veysel Tahan, MD, FACG, Jamal A. Ibdah, MD, PhD, FACG Melanoma Immune Checkpoint Inhibitors-Induced Colitis, Stay Vigilant! P1488. The American Journal of Gastroenterology. 114:S823-S824, October 2019. 5) Syed Bilal Pasha, MD, Veysel Tahan, MD, FACG, Jaffar Hilli, MD, Ghouri Yezaz, MD Treatment of Checkpoint- inhibitor Induced Colitis Leading to Worsening of Melanoma. P2061. The American Journal of Gastroenterology. 114:S1153, October 2019. 6) Zachary Smith, MD, Ghouri Yezaz, MD, Jamal A. Ibdah, MD, PhD, FACG, Veysel Tahan, MD, FACG. Ulcerative Colitis With Concomitant Serrated Polyposis Syndrome. P1527. The American Journal of Gastroenterology. 114:S845, October 2019. 7) Suha Abu Khalaf, MD, Mohamad Yousef, MD, Abdulmajeed Albarrak, MD, Vanessa Kuwajima, MD, Jamal A. Ibdah, MD, PhD, FACG, Veysel Tahan, MD, FACG. Acute Liver Failure Caused by Hemophagocytic Lymphohistiocytosis Secondary to Aggressive Natural Killer Cell Leukemia and Epstein-Barr Virus Reactivation. P2366. The American Journal of Gastroenterology. 114:S1316, October 2019. 8) Ravinder Mankoo, MD, Lybia Malik, Mustafa Habib, Zachary Smith, MD, Vanessa Kuwajima, MD, Jamal A. Ibdah, MD, PhD, FACG, Veysel Tahan, MD, FACG. Metastatic Neuroendocrine Tumor of Unknown Primary Presenting as Acute Gastrointestinal Bleed With Hemorrhagic Shock. P2031. The American Journal of Gastroenterology. 114:S1137, October 2019. 9) Ali A, Dailey F, Hammoud G, Al-Juboori A, Rao DS, Tahan V, Tuncer T. Idiopathic Eosinophilic Syndrome With Hepatic Involvement. P2499. The American Journal of Gastroenterology. 114:S1373- S1374, October 2019. 10) Rossow B, Ghassan H, Tahan V. Endoscopic Ultrasound-Guided Drainage and Treatment of Symptomatic Walled-Off Pancreatic Necrosis: A Single Center Case Series. P2937. The American Journal of Gastroenterology. 114:S1599-S1600, October 2019.

Digestive Disease Week® (DDW) 2019 at the San Diego Convention Center in San Diego, CA, May 18-21, 2019. 11) Romana BS, Yousef MH, Jasmine Hundal, Boumitri C, Tahan V, Samiullah S, Hammoud GM. The outcome of endoscopic mucosal resection of cecal polyps involving the appendiceal orifice. Abstract # 3156059. 12) Dailey FE, Turse EP, Hammoud GM, Tahan V. The clinical utility of endoscopic ultrasound for rectal and perirectal lesions: a large center experience. Abstract # 3137271. 13) Yousef MH, Albarrak AA, Tahan V, Romana BS, Yousef Mousa, Esebua M, Samiullah S, Ibdah JA, Hammoud GM. Utility of endoscopic ultrasound-guided fine needle aspiration in the evaluation of periportal lymphadenopathy in patients with chronic liver disease. Abstract # 3154054. 14) Yousef MH, Syed Bilal Pasha, Yousef Mousa, Albarrak AA, Juboori AA, Rong Chen, Frazier SR, Tahan V. Lymphocytic esophagitis: a case series of esophageal disease with increasing frequency. Abstract # 3156960.

American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 2018 in San Francisco, CA, November 9- 13, 2018 15) Tran KD, Kuwajima VK, Tahan V. Impact of obesity on treatment of chronic hepatitis C in interferon-free direct- acting antiviral era. Abstracts Supplement (Poster)681, Hepatology 2018;68:suppl 1: 404A.

American College of Gastroenterology (ACG) 2018 at the Pennsylvania Convention Center in Philadelphia, PA, October 5- 10, 2018 16) Rossow B, Tahan V, Bechtold ML, Samiullah S, Bragg JD. P1174 - A Hard Pill to Swallow: Esophageal Intramural Pseudodiverticulosis:1755. American Journal of Gastroenterology. 113:S1002, October 2018. 17) Dailey FE, Turse EP, Naseer M, Tahan V. P0401 - A Rare Cause of Hematochezia Necessitating Surgical Resection: Massive Colonic Angiodysplasia: 1923. American Journal of Gastroenterology. 113:S1093A, October 2018.. 18) Dailey FE, Turse EP, Naseer M, Tahan V. P0494 - An Unusual Side Effect of Interferon Therapy: 2038. American Journal of Gastroenterology. 113:S1163, October 2018.. 19) Romana BS, Mankoo R, Tahan V, Samiullah S, Hammoud GM. P0190 - Collision Tumor: A Unique Combination of Tubulovillous Adenoma and Goblet Cell Carcinoid of Colon: 1503. American Journal of Gastroenterology. 113:S863, October 2018. 20) Romana BS, Jasmine Hundal, Yousef MH, Kuwajima-Smith VK, Bechtold ML, Tahan V. P0317 - Esophageal Parakeratosis: Not All White Plaques Are Candida: 1740. American Journal of Gastroenterology. 113:S993-S994, October 2018.. 21) Turse EP, Dailey FE, Tahan V, Turse JC. P2474 - Unusual Presentation of a Rare Hepatic Tumor. 22) Cockerell C, Mankoo R, Dailey FE, Samiullah S, Hammoud GM, Tahan V. P0282 - When Esophagus Met Bronchus: Not a Love Story: 1705 American Journal of Gastroenterology. 113:S972-S973, October 2018..

Digestive Disease Week® (DDW) 2018 at the Walter E. Washington Convention Center in Washington, DC, June 2-5, 2018 23) Albarrak AA, Yousef MH, Hammoud GM, Samiullah S, Ibdah JA, Tahan V. Mo1094: The utility of endoscopic overstitch for the prevention of stent migration in the upper gastrointestinal tract. 24) Yousef MH, Albarrak AA, Tahan V, Romana BS, Esebua M, Samiullah S, Ibdah JA, Hammoud GM. Mo1311: Utility of endoscopic ultrasound-guided fine needle aspiration in the evaluation of enlarged periportal lymph nodes. 25) Romana BS, Hudhud D, Hammoud GM, Tahan V, Ibdah JA, Fatima Samad, Samiullah S. Mo2003: Safety of transesophageal echocardiography in patients with gastroesophageal varices. 26) Romana BS, Chela H, Yousef MH, Tahan V, Ibdah JA, Samiullah S, Hammoud GM. Mo2004: Outcome of endoscopic mucosal resection of cecal polyps: a retrospective study.

World Congress of Gastroenterology ACG 2017 at the Orange County Convention Center in Orlando, Florida, October 13- 18, 2017 27) Rao SC, Sathyamurthy A, Tahan V. Extra-thoracic Extrinsic Compression: An Unusual Cause of Dysphagia: 1694. American Journal of Gastroenterology. 112:S918, October 2017. . 28) Yousef MH, Chela H, Romana BS, Hammoud GM, Tahan V. Utility of combined endoscopic therapy with balloon dilation and onabotulinum toxin A injection in a patient with gastroparesis secondary to hypertrophic pylorus: 2573. American Journal of Gastroenterology. 112:S1407, October 2017. 29) Mir F, Yousef MH, Partyka EK, Tahan V. Successful Treatment of Chronic Refractory Pouchitis with Vedolizumab: A Case Report. 30) Cockerell C, Romana BS, Hammoud GM, Tahan V. All the Usual Suspects: A Case of Acute Necrotizing Esophagus: 1745. American Journal of Gastroenterology. 112:S950-S951, October 2017. 31) Boumitri C, Rao SC, Ashraf I, Rong Chen, Tahan V. A Case of Severe Erosive Enterocolitis Secondary to CMV Reactivation in a Patient with DRESS Syndrome: 1473. . 32) Boumitri C, Brahmbhatt M, Tahan V. An Unexpected Massive Colonic Dilation On A Chest X-ray:1475. American Journal of Gastroenterology. 112:S806-S807, October 2017. 33) Abdel Jalil A, Amisha Nibber, Mahdi AO, Bechtold ML, Ibdah JA, Tahan V. Early Buried Bumper Syndrome: A Rare Complication of Percutaneous Endoscopic Gastrostomy Tube Placement. American Journal of Gastroenterology. 112:S807-S808, October 2017. 34) Romana B, Albarrak A, Yousef M, Tahan V. Infliximab Use in Inflammatory Bowel Disease Flare WithClostridium difficileInfection: 2916. American Journal of Gastroenterology. 112:S1559, October 2017. 35) Yousef M, Mir F, Partyka E, Tahan V. Successful Treatment of Chronic Refractory Pouchitis With Vedolizumab: A Case Report: 1994 . American Journal of Gastroenterology. 112:S1100-S1101, October 2017. 36) Courtney C, Tahan V, Hammoud G. Mankoo R. When Esophagus Met Bronchus: And It's not a Love Story: 2883. American Journal of Gastroenterology. 112:S1543-S1544, October 2017. 37) Yousef M, Hudhud D, Tahan V, Samullah S, Hammoud GH. Obstructive Jaundice Secondary to Primary Gastroduodenal Burkett's Lymphoma in Retro-positive Patient: A Case Report: 2978. American Journal of Gastroenterology. 112:S1585, October 2017.

American College of Gastroenterology (ACG) 2016 Annual Scientific Meeting and Postgraduate Course at the The Venetian in Las Vegas, Nevada, October 14-19, 2016 38) Mir F, Benjamin Schmidt, Tahan AC, Kuwajima VK, Winn JN, Tahan V. P403 - Isolated terminal ileitis: Crohn’s disease or something else? : 627. American Journal of Gastroenterology. 111:S289, October 2016. 39) Rao SC, Ashraf I, Mir F, Samiullah S, Ibdah JA, Tahan V. P2078 - Dual infection with hepatitis B and Ebstein-Barr virüs presenting with severe jaundice, coagulopathy and hepatitis B virüs chronicity outcome: 1996. American Journal of Gastroenterology. 111:S951-S952, October 2016. 40) Mir F, Bragg JD, Tahan V. P1950 - Hemolytic anemia with infliximab infusion: A case report: 1747. American Journal of Gastroenterology. 111:S835, October 2016. 41) Mir F, Ashraf I, Tahan V, Samiullah S. P262 - An infected duodenal peri-ampullary diverticulum mimicking a pancreatic head abscess: 1516. American Journal of Gastroenterology. 111:S696, October 2016. 42) Winn, Jessica; Sathyamurthy, Anjana; Tahan, Asli C.; Ibdah, Jamal A.; Tahan, Veysel. Rare Cases of Synchronous Colon Adenocarcinoma and Rectal Carcinoid Tumor: 2597. American Journal of Gastroenterology. 111:S1308, October 2016. 43) Mir, F, Achakzai I, Ibdah J, Tahan V. The mysterious case of the pill parasite: 2586. American Journal of Gastroenterology. 111:S1304, October 2016.

24th Conference of Asian-Pacific Association for the Study of the Liver (APASL) in Istanbul, Turkiye, March 12-15, 2015 44) Tahan V, Gramignoli R, Skvorak K, Guzman-Lepe J, Delgado E, Tahan A, Dorko K, Hansel M, Marongiu F, Strom SC. Human amniotic epithelial cell therapy improves survival of d-galactosamine induced acute liver failure in mice.

The 10th Cell Transplant Society Congress - The 36th Japan Society for Organ Preservation and Medical Biology at the Okayama Convention Center in Okayama, Japan, April 20-21, 2009 45) Marongiu F, Gramignoli R, Sicari B, Sambamurthy N, Tahan V, Dorko K, Davila J, Strom SC. Symposium 8: Stem Cells, Mesenchymal Stem Cells & Their Derivates. (Oral Presentation) 46) Gramignoli R, Green ML, Breite AG, McCarthy RC, Marongiu F, Sharma S, Dorko K, Tahan V, Ellis ECS, Geller DA, Venkataramanan R, Fox IJ, Strom SC. S1-07: Evaluation of a new collagenase/protease preparation for the isolation of human hepatocytes. (Oral Presentation) 47) Gramignoli R, Marongiu F, Sharma S, Dorko K, Tahan V, Ellis ECS, Geller DA, Venkataramanan R, Fox I, Strom SC. P-50: Evaluation of human hepatocytes Pre- and Post-hypothermic storage for viability and metabolic capacity. (Oral Presentation) Digestive Disease Week® (DDW) 2008 in San Diego, CA, May 17-22, 2008 48) Yapali S, Deniz M, Eren F, Imeryuz N, Celikel C, Ozkan N, Tahan V, Hamzaoglu H, Tozun N. Is There a Role for Adipocytokines On the Effect of Anti-TNF Treatment in An Experimental Model of Colitis? S1293.

Falk Symposium 163 - Chronic Inflammation of Liver and Gut in HangZhou, China, March 14-15, 2008 49) Tahan V, Canbakan B, Sentürk H, Olgac V, Balci H, Sut N, Hatemi I. Serum Gamma-glutamyltranspeptidase Distinguishes Non-alcoholic Fatty Liver Disease at High Risk.

Falk Symposium 160 - Pathogenesis and Clinical Practice in Gastroenterology in Portoroz, Slovenia, June 15-16, 2007 50) Tahan V, Canbakan B, Senturk H, Olgac V, Balci H, Sut N, Hatemi I. Hepatocyte apoptosis in NAFLD patients with elevated versus normal GGT. P:105 51) Aynacı N, Tahan V, Yardım M. Acute pancreatitis attributed to the use of peginterferon alpha-2b. P:5 52) Canbakan B, Tahan V, Sentürk H, Sut N, Ozbay G. Leptin in non-alcoholic fatty liver disease. P:15 53) Tahan G, Eren F, Tarcin O, Tahan V, Akin H, Sahin H, Gedik N, Ozdogan O, Imeryuz N, Celikel C, Haklar G, Tozun N. The effects of lanreotide and peginterferon alpha-2b therapies on hepatic fibrosis induced by bile duct ligation in rats. P:104

17th Conference of the Asian-Pacific Association for the Study of the Liver (APASL) in Kyoto, Japan, March 27-30, 2007 54) Ozaras R, Tabak F, Kaygusuz A, Tahan V, Ozturk R, Mert A, Senturk H. Apoptotic cell death during HBV treatment: Does it correlate with biochemistry and viral kinetics? Hepatology International 2007; 1 (1): p5: O-015 (Oral Presentation) 55) Ozaras R, Tabak F, Tahan V, Ozturk R, Mert A, Senturk H. Correlation of quantitative assay of HBsAg and HBV DNA levels during chronic HBV treatment. Hepatology International 2007; 1 (1): p7: O-027. (Oral Presentation) 56) Senturk H, Canbakan B, Balcı H, Tahan V, Hatemi I, Ozbay G, Yurdakul I. The role of leptin in the pathogenesis of nonalcoholic fatty liver disease. Hepatology International 2007; 1 (1): p69: O-396. (Oral Presentation) 57) Eren F, Avsar A, Ozdemir O, Tamar D, Tahan V, Karatuna O, Soyletir G, Ozdogan O, Imeryuz N, Avsar E, Tozun N. Occult HBV infection in Turkish IV drug users. Hepatology International 2007; 1 (1): p118: P-0255. 58) Tahan V, Ozaras R, Uraz S, Karaca C, Eren F, Danalioglu A, Turkoglu S, Midilli K, Avsar E, Tabak F, Ozturk R, Mert A, Tozun N, Senturk H. Is HCV genotyping cost-effective in Turkey? Hepatology International 2007; 1 (1): p139: P-0379. 59) Ozdogan O, Tahan V, Cincin A, Imeryuz N, Tozun N. Acute pancreatitis associated with peginterferon and ribavirin therapy in a patient with chronic HCV. Hepatology International 2007; 1 (1): p160: P-0508. 60) Ozdemir F, Eren F, Tiftikci A, Tahan V, Akin H, Gunduz F, Kedrah AE, Tozun N, Ozdogan O. The prevalence of the mutation in codon 249 of the p53 gene in patients with HCC in Turkey. Hepatology International 2007; 1(1): p169: P-0562. 61) Akin H, Deniz M, Can G, Celikel C, Yegen B, Kedrah AE, Tahan V, Tozun N, Imeryuz N. Is animal model for NASH with high fat liquid (Lieber-DeCarli) diet really working? Hepatology International 2007; 1 (1): p226: P-0905. 62) Akin H, Aktolga S, Can G, Tahan G, Ozdogan O, Tahan V, Imeryuz N, Avsar E, Kalayci C, Tozun N. Gastric varice frequency in patients with portal hypertension. Hepatology International 2007; 1 (1): p235: P-0957.

Falk Symposium 157 in Konzerthaus Freiburg, Germany, October 10-11, 2006 63) Tahan G, Tarcin O, Tahan V, Eren F, Gedik N, Sahan E, Biberoğlu N, Guzel S, Bozbas A, Tozun N, Yucel O. The effects of N-acetylcysteine on bile-duct ligation model induced liver fibrosis in rats. p194

European Association for the Study of the Liver (EASL) 2006 in Vienna, Austria, April 26-30, 2006 64) Eren F, Tahan V, Imeryuz V. et al. Iron aggravates Liver İnjury by triggering apoptosis in rat nutritional steatohepatitis. J. Hepatol, Supplement No.2 Vol.44, 2006. S251. (Best Abstracts/Registration Grant Award)

United European Gastroenterology (UEG) Week 2005 in Copenhagen, Denmark, October 15-20, 2005 65) Ozdoğan O, Atalay H, Cimsit C, Akin H, Avsar E, Tuney D, Baltacioglu F, Tahan V, Erzen C, Tozun N. Glucagon is the responsible peptide in postprandial hyperemia of cirrhotic patients. Gut 2005; Suppl 7(54): 198. (G-224).

World Congress of Gastroenterology ACG 2005 in Montreal, Quebec, Canada, September 12-14, 2005 66) Tahan V, Imeryuz N, Eren F, Uzun H, Gogas D, Celikel C, Avsar E, Tozun N. Rosiglitazone has an anti- inflammatory effect by decreasing inflammatory cytokines in a rat model of non-alcoholic steatohepatitis. Canadian J Gastroenterol 2005; 19 suppl B: 7B, PP13. (Presidential Poster and Poster of Distinction Award)

European Association for the Study of the Liver (EASL) 40th Annual Meeting 2005 in Paris, France, April 13-17, 2005 67) Uraz S, Tahan V, Aygun C, Eren F, Yuksel M, Unluguzel G, Ozdogan O, Senturk O, Avsar E, Haklar G, Celikel C, Hulagu S, Tozun N. Role of ursodeoxycholic acid in the prevention of methotrexate induced liver toxicity. J Hepatol 2005; 2(42):255, p698 68) Tahan V, Imeryuz N, Uzun H, Eren F, Gogas D, Barghi I, Celikel C, Avsar E, Tozun N. Rosiglitazone shows an anti-inflammatory effects by decreasing interleukin-6 in a rat model of non-alcoholic steatohepatitis. J Hepatol 2005; 2(42):254, p697 69) Tiftikci A, Zeytinoglu D, Sagnic S, Taneroglu S, Arer I, Bekiroglu N, Tahan V, Tozun N. Awareness of health care staff, HCV infected patients and householh contacts of HCV transmission routes. J Hepatol 2005; 2(42):223, p611

Asian-Pacific Association for the Study of the Liver (APASL) 2004 in New Delhi, India, December 11-15, 2004 70) Tahan V, Ozaras R, Lacevic N, Ozden E, Yemisen M, Ozdogan O, Mert A, Tabak F, Avsar E, Celikel CA, Ozbay G, Kalayci C, Senturk H, Tozun N. Prevalence and therapeutic effect of Hepatic Granulomas In Chronic Hepatitis B. J Gastroenterol Hepatol, Supp1, December 2004. 71) Eren F, Tahan V, Ture F, Avsar E, Mert A, Tozun N, Kalayci C. Do YMDD motive mutations happen spontaneously? J Gastroenterol Hepatol, Supp1, December 2004.

Falk Symposium 142 - Autoimmune Liver Disease (Gastroenterology Week) in Freiburg, Germany, October 12-13, 2004 72) Canbakan B, Sentürk H, Tahan V, Sonsuz A, Balcı H, Dirican A, Ozbay G. Prevalence and significance of non- organ-specific auto antibodies in nonalcoholic fatty liver disease. p12

12th Annual United European Gastroenterology (UEG) Week 2005 in Prague, Czech Republic, September 25-29, 2004 73) Tahan V, AytekinH, Dikici H, Ermis F, Yildirim B, Canbakan B, Senturk H. Oxidative stress is correlated with Truelove and Witts’ disease activity score in ulcerative colitis. Gut 2004;36 (Suppl VI) A308. 74) Yildirim B, Canbakan B, Durak H, Ozaras R, Tahan V, Ozbay G, Senturk H. Immunologic cells in patients with chronic hepatitis C on chronic hemodialysis and changes with treatment in peripheral blood and liver biopsy. Gut 2004;53 (Suppl VI) A171.

Falk Symposium 140 - Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice in Dubrovnik, Croatia, May 7-8, 2004 75) Canbakan B, Sentürk H, Tahan H, Yildirim B, Ozbay G, Hatemi I, Oktay E. Neutrophil oxidative burst: A possible pathogenic mechanism fortissue damage in ulcerative colitis.

European Association for the Study of the Liver (EASL) 39th Annual Meeting 2005 in Berlin, Germany, April 14-18, 2004 76) Tahan V, Avsar E, Eren F, Yavuz D, Emekli E, Yuksel M, Goren Z, Imeryuz N, Celikel C, Haklar G, Tozun N. The effect of rosiglitazone on methionine and choline deficient diet model of non-alcoholic steatohepatitis in rats. J Hepatol 2004;40 (Suppl. 1):172. 77) Tahan V, Sonsuz A, Imeryuz N, Uraz S, Akpulat S, Yuksel M, Ozcelik D, Avsar E, Celikel C.A, Haklar G, Tozun N. Parenteral Iron Enhences Liver Injury In Methionine Choline Deficient Diet Induced Non-Alcoholic Steatohepatitis In Rats. J Hepatol 2004;40 (Suppl. 1):171.

Egyptian Association of Gastroenterology and Liver Disease (ESGLD) Conference in Cairo, Egypt, March 1-4, 2004 78) Bozbas A, Eren F, Tahan V, Duman D, Tiftikci A, Tozun N. Role of transforming growth factor B-1 in course of chtonic HBV infection. p158 (Oral Presentation)

13th World Congress of the Association of Surgeons & Gastroenterologists in Estoril, Portugal, December 3-6, 2003 79) Duman DG, Tahan V, N. Alpay, H. Tanınmıs, G. Haklar, Ç. Çelikel, Avsar E, Kalaycı C1, Tözün N1. Marmara1 and Istanbul University, İstanbul, Turkey. Is Serum Hyaluronic Acid A Surrogate Marker Predicting the Liver Fibrosis in NAFLD?

XII Falk Liver Week 2003 in Freiburg, Germany, October 17-19, 2003 80) Tahan V, Yildirim B, Ture F, Giral A, Ozdogan O, Imeryuz N, Avsar E, Mert A, Senturk H, Kalayci C, Tozun N. Anti-HCV Seroprevalence in Chronic HCV Patient’s Children in Turkey. 81) Yildirim B, Aygun C, Tahan V, Besler M, Ozaras R, Demir G, Senturk H. Dendritic cell count in patients with chronic hepatitis C and their change with treatment. 82) Furuncuoglu Y, Tahan V, Bunyak B, Ersoy D, Ozdemir A. HbsAg prevalence in Istanbul.

Falk Symposium 134 - Trends and Controversies in IBD-Evidence Based Approach or Individual Management? in Berlin, Germany, June 12-13, 2003 83) Bozbaş A, Tahan V, Hamzaoglu HO, Tozun N. Appendectomy and inflammatory bowel disease in the Turkish population. p53 84) Yilmaz M, Tahan V, Bozbaş A, Hamzaoglu HO, Tozun N. Seasonal influence in exacerbations of inflammatory bowel disease. p90

13th European Congress of Clinical Microbiology and Infectious Diseases in Glasgow, UK, May 10-13, 2003 85) Ozaras R, Tahan V, Mert A, Tabak F, Avsar E, Ozbay G, Celikel C, Tozun N, Senturk H. The prevalence of hepatic granulomas in chronic hepatitis C. (Oral Presentation).

European Association for the Study of the Liver (EASL) 38th Annual Meeting 2003 in Geneva, Switzerland, March 29-April 1, 2003 86) Tahan V, Eren F, Yavuz D, Emekli E, Yuksel M, Goren Z, Celikel C, Haklar G, Avsar E, Tozun N. Rosiglitazone attenuates liver inflammation in a rat model of non-alcoholic steatohepatitis. J Hepatol; 2003:38-Supp 2: 202, abst 700. 87) Tahan V, Karaca C, Yildirim B, Bozbas A, Demir K, Avsar E, Mert A, Tabak F, Besisik F, Kaymakoglu S, Senturk H, Cakaloglu Y, Kalayci C, Okten A, Tozun N. Sexual transmission of HCV between spouses. J Hepatol; 2003:38- Supp 2: 176, abst 605. 88) Tasan G, Tozun N, Tahan V, Enc FY, Giral A, Imeryuz N, Avsar E, Kalayci C. Assesment of nutrition in liver cirrhosis. J Hepatol; 2003:38-Supp 2: 201, abst 699.

6th African Association for Study of Liver Disease in Cairo, Egypt, March 3-6, 2003 89) Tahan V, Karaca C, Uslu E, Eren F, Aydin S, Uzun H, Hamzaoglu HO, Besisik F, Avsar E, Kalayci C, Okten A, Tozun N. Adrenomedullin: A Trigger or Bystander in Cirrhotic and Non-Cirrhotic Portal Hypertension?, p32 (Oral Presentation)

2nd International Meeting on Free Radicals in Health and Disease in Istanbul, Turkey, May 8-12, 2002 90) Aytekin H, Tahan V, Aydın S, Uzun H, Altuğ T, Oktay E. The effect of vitamin-E on acetic acid induced colitis model in rats. p108 91) Aydın S, Ozaras R, Uzun H, Belce A, Altuğ T, Tahan V, Uslu E, Dümen E, Senturk H. N-acetyl cysteine mitigate the toxic effects of ethanol on the oxidant-antioxidant system of rat plasma and brain. p106

American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 2001 at the Wyndham Anatole in Dallas, Texas, November 9-13, 2001 92) Tahan V, Ozaras R,Uzun H, Aydin S, Bayrak I, Altug T, Dondurmaci S, Senturk H. The Effect Of Melatonin On Dimethylnitrosamine-Induced Liver Fibrosis In Rats. Abst. 890 (Oral Presentation)

Falk Workshop in Istanbul, Turkey, June 16, 2001 93) Tahan V, Ozaras R,Uzun H, Aydin S, Bayrak I, Altug T, Dondurmaci S, Senturk H. The Effect Of Melatonin On Dimethylnitrosamine-Induced Liver Fibrosis In Rats. (Oral Presentation) 94) Ozaras R, Tahan V,Uzun H, Aydin S, Dondurmaci S, Senturk H. N-acetyl cysteine attenuates alcohol-induced oxidative stress in the rat. (Oral Presentation)

Digestive Disease Week® (DDW) in Atlanta, Georgia, May 20-23, 2001 95) Ozaras R, Tahan V,Uzun H, Aydin S, Dondurmaci S, Senturk H. N-acetyl cysteine attenuates alcohol-induced oxidative stress in the rat. p627 (Oral Presentation)

11th European Congress of Clinical Microbiology and Infectious Diseases in Istanbul, Turkey, April 1-4, 2001 96) Tahan V, Ozaras R, Mert A, Tabak F, Celik A, Ozturk R, Ozbay G, Uzunismail H, Aktuglu Y. Infectious mononucleosis presenting with severe cholestatic liver disease in the elderly. 97) Tahan V, Ozaras R, Mert A, Tabak F, Cagatay T, Senturk H. Sarcoidosis developed after use of interferon for chronic hepatitis C. 98) Mert A, Ozaras R, Tahan V, Tabak F, Ozbay G, Aktuglu Y, Senturk H. Hepatic granulomas in chronic hepatitis C.

XXXVII Congress of the European Renal Association European Dialysis and Transplant Association in Nice, France, September 17-20, 2000 99) Altiparmak MR, Ataman R, Özaras R, Tahan V, Uzun H, Aydin S, Serdengeçti K, Erek E, Soysal T. Erythrocytes in patients with renal failure on CAPD. p345 (Oral Presentation)

10th European Congress of Clinical Microbiology and Infectious Diseases in Stockholm, Sweden, May 28-31, 2000 100) Mert A, Bilir M, Ozaras R, Cetinkaya A, Tahan V, Yirmibescik S, Tabak F, Ozturk R, Ozbay G, Aktuglu Y, Senturk H. Significance of infectious diseases in etiology of hepatic granulomas: Evaluation of 74 cases. p151

United European Gastroenterology (UEG) Week 1999 in Rome, Italy, November 15-17, 1999 101) Canbakan C, Dobrucali A, Celik A, Tahan V, Goksel S, Tuncer M, Uzunismail H, Yurdakul I, Oktay E, Hekim N, Dundar G. Gastritis location and Gord 73.11 incidence in patients with A (+) H. pylori infection. (Oral Presentation)

IV Congress of Balkan Cities Association of Nephrology, Dialysis, Transplantation and Artificial Organs in İzmir, Turkey, November 14-16, 1999 102) Apaydın S, Ozaras R, Sipahioglu MH, Cetinkaya A, Tahan V, Sarıyar M, Ataman R, Serdengeçti K, Erek E. Long term follow-up of living kidney donors. p16

American Society of Clinical Oncology in Atlanta, Georgia, May 15-18, 1999 103) Ozguroglu M, Tahan V, Demir G, Ozaras R, Demirelli F, Mandel N, Buyukunal E, Serdengecti S, Berkarda B. Significance of serum beta-2 mikroglobulin in epithelial ovarian cancer., p382a, 1474. (Oral Presentation)

9th European Congress of Clinical Microbiology and Infectious Diseases in Berlin, Germany, March 21-4, 1999 104) Demirci M, Yorgancigil B, Tahan V, Arda M. Investigation of seropositivity and vectors of Lyme disease in the Isparta region of Turkey. p257 (Oral Presentation)

5th Annual Meeting of The Oxygen Society in Washington, D.C., November 19-23, 1998 105) Ozaras R, Tahan V, Unlu M, Demirci M, Bahceci M, Uzun H, Aydın S, Delibas N. Lp(a) levels and lipid peroxidation after smoke exposure in the rabbit. pS77 106) Ozaras R, Tahan V, Aydın S, Uzun H, Oztekin G, Tunckale A, Dondurmaci S. A non-sulfhydryl ACE inhibitor, fosinopril, attenuates oxidative stress in essential hypertension. pS95

International Association for the study of the Liver Biennial Scientific Meeting in Chicago, IL, November 4-6, 1998 107) Tabak F, Ozaras R, Tahan V, Mert A, Akdogan M, Sentürk H. The effect of diabetes mellitus on the treatment of chronic hepatitis C with interferon. p705A

15th International Congress on Thrombosis in Antalya, Turkey, October 16-21, 1998 108) Ongören S, Tahan V, Özaras R, Dobrucalı A, Önay H, Albayrak ZK, Numan F, Aydın Y. Hereditary telengiectasia manifested as recyrrent gastrointestinal bleeding for 12 years: A case report. p351

FEMS Symposium - Recent Advantaces in the Diagnosis of Sexually Transmitted Diseases in Istanbul, Turkey, June 10-13, 1998 109) Mert A, Tabak F, Tahan V, Yıldırım B, Ozaras R, Otağ F, Öztürk R, Aktuğlu Y, Şentürk H. Infectivity of chronic asymptomatic HBsAg carriers for their spouses. p50 110) Mert A, Tabak F, Ozaras R, Yıldırım B, Tahan V, Seyhan EC, Otağ F, Akdoğan M, Aktuğlu Y, Şentürk H. Transmission of hepatitis C between spouses. p52

European Association for the Study of the Liver (EASL) Postgraduate Course in İstanbul, Turkey, June 26, 1998 111) Mert A, Yıldırım B, Otağ F, Bilir M, Tabak F, Akdoğan M, Tahan V, Ozaras R, Türkoğlu S, Aktuğlu Y, Şentürk H. HCV-RNA positive blood donors: A histologic study. p26 112) Tabak F, Tahan V, Özaras R, Mert A, Yıldırım B, Akdoğan M, Şentürk H. Coinfection with hepatitis B and C in patients with chronic hepatitis: Effects of interferon treatment. p27 113) Tabak F, Özaras R, Tahan V, Mert A, Akdoğan M, Şentürk H. The effect of diabetes mellitus on the treatment of chronic hepatitis C with interferon. p28

NATO Advanced Study Institute on Free Radicals, Oxidative Stress, and Antioxidants: Pathological and Physiological Significance in Antalya, Turkey, May 24-June 4, 1997 114) Delibas N, Tahan V, Durmuş M. SOD, GPx and MDA levels in type II diabetes mellitus cases with or without retinopathy. p150

Conference Presentations in Turkey 31 Turk Gastroenteroloji Haftasi, November 25-30, 2014, Antalya 1) Veysel Tahan, Roberto Gramignoli, Kristin Skvorak, Jorge Guzman-Lepe, Evan Delgado, Asli Tahan, Kenneth Dorko, Mark Hansel, Fabio Marongiu, Stephen Strom. Plasental amniotik epitelyal hücre tedavisi D-Galaktozamin ile geliştirilen modelde akut karaciğer yetmezliğini iyileştirir. p30 2) Asli Ceren Tahan, Veysel Tahan. Hepatosite farklılaşmaya uygun kültürde yüzen ve kültür tabanına yerleşen plasental amniotik membran hücrelerinin kök hücre özellikleri. p29

6 Hepatogastroenteroloji Kongresi, 2009, Antalya 3) Tahan G, Tahan V et al, Melatoninin BDL ile induklenen karaciger fibrozu uzerine etkisi. (Oral Presentation)

24 Ulusal Gastroenteroloji Haftası UGH, 16-21 Ekim 2007, Nevşehir 4) Tahan V, Atuğ Ö, Eren F, Akın H, Uzun H, Özdoğan O, İmeryüz N, Çelikel Ç, Avşar E, Tözün N. Melatoninin metionin ve kolinden yoksun diyetle geliştirilen nonalkolik steatohepatit modelde hepatosit apoptozu, inflamasyon belirteçleri ve histopatoloji üzerine etkisi. Turk J Gastroenterol 2007; 18 (Suppl 1): 17 (SS-35). (Oral Presentation) 5) Yapalı S, İmeryüz N, Eren F, Deniz M, Çelikel Ç, Özkan N, Tahan V, Yavuz D, Hamzaoğlu H, Tözün N. Adipositokinlerin deneysel intestinal inflamasyon modelinde ve anti-TNF tedavi sonrasında inflamasyon sürecine etkisi. Turk J Gastroenterol 2007; 18 (Suppl 1): 20 (SS-43). 6) Tahan V, Sayrak H, Bayar N, Tahan G, Yardım M. Doksisiklin ile gelişen özofagus kanserini taklit eden ülserler. Turk J Gastroenterol 2007; 18 (Suppl 1): 33 (PS-19).

4 Hepato Gastroenteroloji Kongresi, 1-5 Eylül 2007, Su Sesi Otel Deluxe, Antalya 7) Hakan Şentürk, Veysel Tahan, Billur Canbakan, Faysal Dane, Yakup Ülger, Reşat Özaras, Fehmi Tabak, Ali Mert, Gülşen Özbay. Kronik hepatit B ve C koenfeksiyonlu hastalarımızın klinikopatolojik özellikleri: Kronik hepatit B, C ve Delta enfeksiyonlularla karşılaştırmalı değerlendirme. PB-70, S:316. 8) Veysel Tahan, Billur Canbakan, Huriye Balcı, ibrahim Hatemi, Özlen Atuğ, Necdet Sut, Münire Hacıbekiroğlu, Neşe İmeryüz, Hakan Şentürk. Leptin non-alkolik yağlı karaciğer hastalığı patogenezinde önemli mi? PB-71, S:317. 9) Veysel Tahan, Billur Canbakan, Huriye Balcı, İbrahim Hatemi, Vakur Olgaç, Abdullah Sonsuz, Gülşen Özbay, İbrahim Yurdakul, Hakan Şentürk. Gamma glutamil transpeptidaz düzeyi yağlı karaciğer hastalığında prognostik faktörmüdür? PB-72, S:318. 10) Veysel Tahan, Hakan Sayrak, Nevzat Bayar, Gülgün Tahan, Mithat Yardım. Doksisikline bağlı gelişen ve özofagus kanserini taklit eden özofagus ülserleri. PB-111, S:361.

6th National Hepatology Meeting of TASL, June 7-10, 2007, Istanbul 11) Hakan Şentürk, Veysel Tahan, Billur Canbakan, Yakup Ülger, Güray Can, Reşat Özaras, Fehmi Tabak, Ali Mert, Gülşen Özbay. S32: Kronik Hepatit B ve C Koenfeksiyonunda Standard veya Pegile İnterferon ve Ribavirin Kombinasyonlu Tedavilere Yanıt Düşüktür. Hepatology Forum Vol.1 Number 1 / JUNE 2007. Sy: 44. (Oral Presentation). 12) Filiz Özdemir, Fatih Eren, Arzu Tiftikçi, Veysel Tahan, Hakan Akın, Feyza Gündüz, Alla Elden Kedrah, Deniz Duman, Yücel Üstündağ, Nurdan Tözün, Osman Özdoğan. S22: Hepatoselüler Karsinomalı Vakalarda Aflatoksine Bağlı Oluşan, p53 Kodon 249 Mutasyon Taraması. Hepatology Forum Vol.1 Number 1 / JUNE 2007. Sy: 39. (Oral Presentation). 13) Hakan Akın, Osman Özdoğan, Gülçin Kantarcı, Özlen Atuğ, Veysel Tahan, Çetin Özener, Cem Kalaycı, Nurdan Tözün. Deprem sonrası CRUSH Sendromu gelişen hastalarda aminotransferaz enzim yüksekliği ve seyri. Hepatology Forum Vol.1 Number 1 / JUNE 2007. P004: Sy: 47. 14) Veysel Tahan, Gülgün Tahan, Faysal Dane, Süleyman Uraz, Mithat Yardım. Kronik hepatit C hastasında pegile- interferon ve ribavirin tedavisi sırasında gelişen akut pankreatit olgusu. Hepatology Forum Vol.1 Number 1 / JUNE 2007. P106 Sy: 105. 15) Hakan Akın, Yeşim Özen Al-ahdab, Veysel Tahan, Neşe İmeryüz, Özlen Atuğ, Osman Özdoğan, Nurdan Tözün. Kronik hepatit C tedavisi esnasında gelişen bir interstisyel pnömonitis olgusu. Hepatology Forum Vol.1 Number 1 / JUNE 2007. P109: Sy: 107.

23 Ulusal Gastroenteroloji Kongresi, 04-07 Kasım 2006, İstanbul 16) Reşat Özaras, Fehmi Tabak, Arif Kaygusuz, Veysel Tahan, Recep Öztürk, Ali Mert, Hakan Şentürk. HBV Tedavisi sırasında apoptotik hücre ölümünün biyokimyasal ve viral kinetiklerle ilişkisi. Turk J Gastroenterol;17 (Supp1): s5, SB.00/02. (Oral Presentation). 17) Alla Eldeen Kedrah, Mustafa Deniz, Fatih Eren, Veysel Tahan, Hızır Kurtel, Çiğdem Çelikel, Goncagül Haklar, Hafize Uzun, Erol Avşar, Nurdan Tözün, Neşe İmeryüz. Glukagon Benzeri Peptid-1 (GLP-1), Metiyonin ve Kolinden Eksik Diyetle (MKED) İndüklenen Sıçan Non-alkolik Steatohepatitini Pro-İnflamatuar Sitokinler ve Apoptozu Azaltarak İyileştirir. Turk J Gastroenterol;17 (Supp1): s9, SB.01/04. (Oral Presentation). 18) Veysel Tahan, Reşat Özaras, Süleyman Uraz, Çetin Karaca, Fatih Eren, Ahmet Danalıoğlu, Salih Türkoğlu, Kenan Midilli, Erol Avşar, Fehmi Tabak, Recep Öztürk, Ali Mert, Nurdan Tözün, Hakan Şentürk. Kronik HCV hastalarında tedavi öncesi genotip tayininin maliyet-etkinliği. Turk J Gastroenterol;17 (Supp1): s17, SB.03/04. (Oral Presentation). 19) Billur Canbakan, Hakan Şentürk, Vakur Olgaç, Huriye Balcı, Veysel Tahan, İbrahim Hatemi, Abdullah Sonsuz, Gülşen Özbay, İbrahim Yurdakul. GGT yüksekliği olan ve olmayan non-alkolik yağlı karaciğer hastalığında apoptoz. Turk J Gastroenterol;17 (Supp1): s73, SB.17/01. (Oral Presentation). 20) Billur Canbakan, Hakan Şentürk, Huriye Balcı, Veysel Tahan, İbrahim Hatemi, Gülşen Özbay, İbrahim Yurdakul. Non- alkolik yağlı karaciğer hastalığı patogenezinde leptinin rolü var mı? Turk J Gastroenterol;17 (Supp1): s73, SB.17/02. (Oral Presentation). 21) Fatih Eren, Veysel Tahan, Neşe İmeryüz, Abdullah Sonsuz, Can Erzik, Ayşe Özer, Goncagül Haklar, Çiğdem Çelikel, Erol Avşar, Nurdan Tözün. Demir, Deneysel Nutrisyonel Steatohepatit Modelinde Karaciğer Hasarını Apoptozu Tetikleyerek Şiddetlendirir. Turk J Gastroenterol;17 (Supp1): s74, SB.17/06. (Oral Presentation). 22) Osman Özdoğan, Veysel Tahan, Altuğ Çinçin, Neşe İmeryüz, Nurdan Tözün. Kronik hepatit C’li hastada peg- interferon alfa-2b ve ribavirin tedavisi sırasında gelişen akut pankreatit vakası. Turk J Gastroenterol;17 (Supp1) :s154, PB.06/7. 23) Fehmi Tabak, Veysel Tahan, Filiz Özdemir, Ömür Tabak, Reşat Özaras. Uzamış anti-HAV IgM pozitifliği ile seyreden otoimmün hepatit ve akut hepatit A olgusu: Vaka sunumu. Turk J Gastroenterol;17 (Supp1): s194, PB.09/13. 24) Osman Özdoğan, Hakan Akın, Veysel Tahan, Neşe İmeryüz, Nurdan Tözün. Kronik hepatit tedavisi esnasında gelişen bir interstisyel pnömonitis olgusu. Turk J Gastroenterol;17 (Supp1): s203, PB.09/52. 25) Fatih Eren, Alla Eldeen Kedrah, Can Erzik, Mustafa Deniz, Veysel Tahan, Hızır Kurtel, Çiğdem Çelikel, Erol Avşar, Ayşe Özer, Nurdan Tözün, Neşe İmeryüz. Difenilamin yöntemi karaciğer hastalıklarında apoptoz tayini için iyi bir alternatif yöntemdir. Turk J Gastroenterol;17 (Supp1): s217, PB.11/12. 26) Gülgün Tahan, Fatih Eren, Orhan Tarçın, Veysel Tahan, Hakan Akın, Hülya Şahin, Nursal Gedik, Osman Özdoğan, Neşe İmeryüz, Çiğdem Çelikel, Goncagül Haklar, Nurdan TÖZÜN. Lanreotid ve peginterferon alfa-2b tedavilerinin koledok ligasyon yöntemi ile oluşturulan deneysel karaciğer fibrozu üzerine etkisi. Turk J Gastroenterol;17 (Supp1): s227, PB.12/20. 27) Orhan Tarçın, Veysel Tahan, Aysun Bozbaş, Berna Oktar, Nursal Gedik, Erol Avşar, Çiğdem Çelikel, Osman Özdoğan, Nurdan Tözün. Etanerceptin koledok ligasyonu ve dimetilnitrözamin yöntemi ile oluşturulan deneysel hepatik fibroz modelleri üzerindeki etkileri. Turk J Gastroenterol;17 (Supp1): s228, PB.12/21. 28) Hakan Akın, Serdal Aktolga, Osman Özdoğan, Güray Can, Gülgün Tahan, Neşe İmeryüz, Adnan Giral, Deniz Duman, Özlen Atuğ, Arzu Tiftikçi, Veysel Tahan, Hülya Hamzaoğlu, Erol Avşar, Cem Kalaycı, Nurdan Tözün. Siroz ve portal hipertansiyon hastalarında gastrik varis sıklığı; 15 yıllık deneyim sonuçları. Turk J Gastroenterol;17 (Supp1): s229, PB.12/28. 29) Hakan Akın, Veysel Tahan, Zekaver Odabaşı, Hüseyin Atalay, Hüseyin Koçak, Gülçin Kantarcı, Çetin Özener, Osman Özdoğan, Nurdan Tözün. Crush sendromu gelişen hastalarda aminotransferaz yüksekliği ve izlem. Turk J Gastroenterol;17 (Supp1): s258, PB.14/69. 30) Hakan Akın, Mustafa Deniz, Veysel Tahan, Güray Can, Alla Eldeen Kedrah, Çiğdem Çelikel, Berrak Yeğen, Nurdan Tözün, Neşe İmeryüz. Önerilen “Lieber- DeCarli” non-alkolik steatohepatit (NASH) hayvan modelinin işlerliğinde başarısızlık. Turk J Gastroenterol;17 (Supp1): s258, PB.14/70.

3 Hepato Gastrtoenteroloji Kongresi, 2-6 Eylül 2006, WOW Kremlin Palace, Antalya 31) Tabak F, Tahan V, Gündüz F, Tabak Ö, Özaras R. Sertraline bağlı hepatotoksisite: Vaka taktimi. Endoskopi 2006; 16: P-68, Sy 201.

5 Ulusal Hepatoloji Kongresi, 5-7 Haziran 2005, Swissotel İstanbul 32) Tahan V, İmeryüz N, Eren F, Gogas D, Uzun H, Celikel C, Avsar E, Tozun N. Rosiglitazon, MCD diyetle geliştirilen NASH modelinde inflamatuar sitokinleri azaltıp inflamasyonu iyileştirir. s15, Ref:109. (Oral Presentation). 33) Cakaloglu Y, Okten A, Pinarbasi B, Besisik F, Gunsar F, Kaymakoglu S, Tahan V, Behcelioglu İH, Idilman R, Sokmen M, Kayhan B, Akin P. Akut C hepatitinde klinik özellikler ve tedavi. S27, Ref:320. (Oral Presentation). 34) Eren F, Avsar M, Özdemir FT, Tamar D, Tahan V, Gurata O, Soyletir G, Ozdogan O, Imeryuz N, Avsar E, Tozun N. Damariçi madde bağımlılarında okült HBV infeksiyonu. s17, Ref:334. (Oral Presentation). 35) Senturk H, Tahan V, Canbakan B, Ulger Y, Ozaras R, Tabak F, Mert A, Ozbay G. Kronik hepatit B ve C dual enfeksiyonunun klinik ve prognozunun kronik hepatit B, C ve Delta enfeksiyonuyla kıyaslanması. s18, Ref:208. (Oral Presentation). 36) Eren F, Ozdemir FT, Tiftikci A, Tahan V, Barghi I, Ozdogan O, Imeryuz N, Avsar E, Tozun N. Ülkemizdeki hepatit C virus genotip profili değişiyor mu? s25, Ref:335. (Oral Presentation). 37) Atalay, H, Akin H, Ozdogan O, Cimsit C, Avsar E, Baltacioglu F, Tuney D, Erzen C, Tahan V, Tiftikci A, Kalayci C, Tozun N. Postprandial portal hiperemide adrenomedullin, nitrik oksit ve glukagon. s46, P015. 38) Tiftikci A, Ozdogan O, Sancak S, Tahan V, Barghi I, Avsar E, Imeryuz N, Duman D, Giral A, Bozbas A, Kalayci C, Tozun N. Sirotik hastalarda hepatoselüler kanser oluşumunda prediktif faktörler ve surveylansın yaşam süresi üzerine etkisi. s55, P033. 39) Canbakan B, Senturk H, Tabak F, Akdogan M, Tahan V, Mert A, Sut N, Ozaras R, Midilli K, Ozbay G. Kronik Delta hepatiti tedavisinde IFN alfa-2B ve lamivudin kombinasyonunun IFN alfa-2B monoterapisiyle karşılaştırılması. s68, P053.

22 Ulusal Gastroenteroloji Haftası UGH, 30 Ağustos-4 Eylül 2005, Malatya 40) Tarcin O, Gedik N, Tahan V, Oktar B, Yegen B, Celikel C, Tozun N. Değişken süreli koledok ligasyonu ile oluşturulan karaciğer fibrozunda non-invaziv belirteç olarak serum prolidazı ve insülin benzeri büyüme faktörü-1 (IGF-1). Turk J Gastroenterol 2005; 16 Suppl 1: 5, SB.00/2. 41) Kedrah A, Deniz M, Tahan V, Kurtel H, Celikel C, Haklar G, Avsar E, Tozun N, Imeryuz N. Glukagon benzeri peptid- 1’in (GLP-1) metionin ve kolinden eksik diyetle (MKED) indüklenen sıçan nonalkolik steatohepatit modeli üzerindeki etkisi. Turk J Gastroenterol 2005; 16 Suppl 1: 24, SB.03/6. (Oral Presentation and “Best Study Award). 42) Tahan G, Tarcin O, Tahan V, Eren F, Gedik N, Sahan E, Biberoglu N, Guzel S, Bozbas A, Tozun N, Yucel O. N- asetilsisteinin deneysel koledok ligasyonu modelinde oksidatif stres ve karaciğer fibrozu üzerine etkisi. Turk J Gastroenterol 2005; 16 Suppl 1: 105, PB.03/11. 43) Bozbas A, Tahan V, Özdemir FT, Duman DG, Celikel C, Tozun N. İnflamatuar barsak hastalıkları aktivitesinde eozinofilinin rolü. Turk J Gastroenterol 2005; 16 Suppl 1: 139, PB.05/49.

21 Ulusal Gastroenteroloji Haftası UGH, 31 Ağustos – 5 Eylül 2004, Antalya 44) Tahan V, Ozaras R, Lacevic N, Ozden E, Yemisen M, Ozdogan O, Mert A, Tabak F, Avsar E, Celikel CA, Ozbay G, Kalayci C, Senturk H, Tozun N. Kronik Hepatit B’de granulomlar ve tedavi üzerine etkisi. Turk J Gastroenterol 2004; 15 Suppl 1: 34, SB.06/6. (Oral Presentation). 45) Tahan V, Yavuz D, Imeryuz N, Avsar E, Tozun N. Oral glucose tolerance deteriorates in rats fed with methionine choline deficient diet. J Hepatology 2004; 41: 352. (Oral Presentation and Best study Award). 46) Tahan V, Ozaras R, Canbakan B, Uzun H, Aydin S, Yildirim B, Aytekin H, Ozbay G, Mert A, Senturk H. Melatonin reduces dimethylnitrosamine-induced liver fibrosis in rats. J Pineal Res 2004; 37:78-84. (Oral Presentation and Best study Award). 47) Uraz S, Tahan V, Aygun C, Eren F, Unluguzel G, Yuksel M, Senturk O, Avsar E, Haklar G, Celikel CA, Hulagu S, Tozun N. Metotreksatın neden olduğu karaciğer toksisitesinin onlenmesinde ursodeoksikolik asidin etkisi. Turk J Gastroenterol 2004; 15 Suppl 1: 10, SB.02/7. (Oral Presentation). 48) Yapalı S, Kefeli U, Tahan V, Barghi I, Atuğ Ö, İmeryüz N, Hamzaoğlu H, Tözün N. İnflamatuar barsak hastalığında fertilite, gebelik, emzirme dönemi ve cinsel yaşam. Turk J Gastroenterol 2004; 15 Suppl 1: 27, SB.05/4. (Oral Presentation). 49) Atuğ Ö, Eren F, Türe F, Tahan V, Bozbaş A, Barghi İ, Tiftikçi A, Hamzaoğlu H, Tözün N. İnflamatuar barsak hastalıklarında peroksizom proliferatör reseptör-gamma (PPAR-γ) geninde PRO12ALA polimorfizminin sıklığı. Turk J Gastroenterol 2004; 15 Suppl 1: 5, SB.01/3. (Oral Presentation). 50) Tahan V, Bozbas A, Atug O, Barghi I, Yilmaz M, Hamzaoglu HO, Tozun N. Mevsimsel değişikliklerin inflamatuar barsak hastalığının aktivasyonu üzerine etkisi. Turk J Gastroenterol 2004; 15 Suppl 1: 168, PB.10/16. 51) Bozbas A, Tahan V, Atug O, Tiftikci A, Hamzaoglu HO, Tozun N. Appendektomi ve inflamatuar barsak hastalıkları. Turk J Gastroenterol 2004; 15 Suppl 1: 170, PB.10/23. 52) Atalay H, Cimsit C, Genc H, Uzun H, Ozdogan O, Baltacioglu F, Tuney D, Tahan V, Giral A, Kalayci C, Tozun N. Post- prandial hiperemi patogenezinde glukagon, nitrik oksit ve adrenomedullin’e göre daha belirgindir. Turk J Gastroenterol 2004; 15 Suppl 1: 188, PB.12/6. 53) Bozbas A, Eren F, Tiftikci A, Tahan V, Duman D, Atug O, Avsar E, Tozun N. Hepatit C virusuna bağlı kronik hepatit seyrinde transforming growth faktor-Beta1’in rolü. Turk J Gastroenterol 2004; 15 Suppl 1: 192, PB.12/23. 54) Yildirim B, Canbakan B, Kisacik B, Aytekin H, Tahan V, Ozbay G, Senturk H. Kronik hepatit C’li hemodiyaliz hastalarında interferon tedavisi. Turk J Gastroenterol 2004; 15 Suppl 1: 198, PB.12/48.

20 Ulusal Gastroenteroloji Haftası UGH, 30 Eylül- 5 Ekim 2003, Kuşadasi 55) V. Tahan, A. Sonsuz, N. İmeryüz, S. Uraz, S. Akpulat, M. Yüksel, D. Özçelik, E. Avşar, Ç.A. Çelikel, G. Haklar, N. Tözün. Metionin ve kolinden eksik diyet ile steatohepatit oluşturulan sıçanlarda parenteral demir yüklemesinin doku hasarı üzerine etkisi. Turk J Gastroenterol 2003; Suppl 1: Sy.9, SB.01/3, ID 495. (Oral Presentation and Best study Award). 56) Özaras R, Tahan V, , Uzun H, Aydın S, Bayrak İ, Altuğ T, Dondurmacı S, Şenturk H. Alkolün sıçanlarda oksidatif strese etkisi ve oksidatif hasarın n-asetilsistein ile azaltılması. (Sözlü Bildiri) (Impakt Faktöre göre Gastroenteroloji alanında 2003 yılında uluslar arasi dergilerde yayinlanan çalismalar arasinda 3. Seçilen Bildiri World J Gastroenterol 2003;9(1):125-8). (Oral Presentation). 57) F. Eren, V. Tahan, F. Türe, E. Avşar, A. Mert, N. Tözün, C. Kalaycı. YMDD motif mutasyonları lamivudin tedavisi almadan da gelişebilir mi? Turk J Gastroenterol 2003; Suppl 1: Sy. 29, SB.05/2 ID 418. (Oral Presentation). 58) V. Tahan, E. Avşar, F. Eren, D. Yavuz, S. Akpulat, E. Emekli, M. Yüksel, G. Ülfer, Z. Gören, N. İmeryüz, HÖ Hamzaoğlu, Ç. Çelikel, G. Haklar, C. Kalaycı, N. Tözün. Rosiglitazonun sıçanlarda metionin ve kolinden eksik diyetle geliştirilen non-alkolik steatohepatit üzerine etkisi. Turk J Gastroenterol 2003; Suppl 1: Sy 138, PB.07/71 ID 491. 59) F. Eren, V. Tahan, F. Türe, A. Mert, E. Avşar, N. Tözün, C. Kalaycı. AntiHBe pozitif asemptomatik HBV taşıyıcıları replikatif m yoksa nonreplikatif mi? Turk J Gastroenterol 2003; Suppl 1: Sy 116, PB.06/55 ID 494. 60) DG Duman, V. Tahan, N. Alpay, H. Tanınmış, G. Haklar, Ç. Çelikel, E. Avşar, C. Kalaycı, N. Tözün. NAFLD’de serum hiyaluronik asit düzeyi karaciğer fibrozunun belirleyicisimidir? Turk J Gastroenterol 2003; Suppl 1: Sy 135 PB.07/57 ID 412. 61) D. Yavuz, N. İmeryüz, SH İpekçi, FY Enç, A. Toprak, İ Akpınar, D. Tüney, S. Akpulat, ÇA Çelikel, G. Haklar, O. Özdoğan, V. Tahan, A. Sonsuz, N. Tözün, S. Akalın. Nonalkolik hepatosteatozlu hastalarda endotel disfonksiyonu ve insülin direnci ilişkilidir. Turk J Gastroenterol 2003; Suppl 1: Sy 137, PB.07/67 ID 475. 62) A.Tiftikçi, D.Zeytinoğlu, S.Sağnıç, S.Taneroğlu, İ.Arer, V. Tahan, I. Barghi, N. Bekiroğlu, N. İmeryüz, N. Tözün. HCV’nin bulaşma yolları, kronik HCV hastaları, HCV’li hastanın yakınları ve sağlık çalışanları tarafından ne kadar biliniyor? Turk J Gastroenterol 2003; Suppl 1: Sy 109, PB.06/25 ID 258.

19 Ulusal Gastroenteroloji Haftası UGH, 1-6 Ekim 2002, Antalya 63) V. Tahan, Ç. Karaca, E. Uslu, F. Eren, S. Aydın, H. Uzun, HÖ Hamzaoğlu, F. Beşışık, E. Avşar, A. Ökten, N. Tözün. Sirotik ve Non-sirotik portal hipertansiyonda adrenomedullin: tetikçi mi? İşaretçi mi? Turk J Gastroenterol 2002: Sy. 46, SB9/6. (Oral Presentation). 64) V. Tahan, Ç. Karaca, B. Yıldırım, A. Bozbaş, K. Demir, E. Avşar, A. Mert, F. Tabak, F. Beşışık, S. Kaymakoğlu, H. Şentürk, Y. Çakaloğlu, C. Kalaycı, A. Ökten, N. Tözün. Hepatit C virüsünün eşler arası geçişi. Turk J Gastroenterol 2002: Sy. 18, SB2/7. (Oral Presentation). 65) V. Tahan, B. Yıldırım, F. Türe, A. Giral, O. Özdoğan, N. İmeryüz, C. Kalaycı, E. Avşar, A. Mert, H. Şentürk, N. Tözün. Kronik hepatit C’li hastaların çocuklarında anti-HCV pozitifliği. Turk J Gastroenterol 2002: Sy. 124, PB7/23.

IV Ulusal Hepatoloji Kongresi, 14-16 Haziran 2001, İstanbul 66) Tahan V, Özaras R, Uzun H, Aydın S, Bayrak İ, Altuğ T, Dondurmacı S, Özbay G, Şenturk H. Melatoninin sıçanlarda dimetilnitrozaminin indüklediği karaciğer fibrozu üzerine etkisi. P- 24 (Oral Presentation). 67) Özaras R, Tahan V, , Uzun H, Aydın S, Bayrak İ, Altuğ T, Dondurmacı S, Şenturk H. Alkolün sıçanlarda oksidatif strese etkisi ve oksidatif hasarın n-asetilsistein ile azaltılması. (Oral Presentation). 68) Tabak F, Şentürk H, Mert A, Tahan V, Özaras R, Uraz S, Yıldırım B, Kumbasar H, İzmir Ş, Özbay G. Kronik Hepatit Polikliniği: 9 yıllık Cerrahpaşa Deneyimi. P-158. 69) Yıldırım B, Tabak F, Barut G, Mert A, Tahan V, Şentürk H. HCV Enfeksiyonunda Risk Faktörleri. P-174. 70) Engin B, Oğuz O, Mert A, Özaras R, Uraz S, Tahan V, Tabak F, Şentürk H. Kronik Hepatit C İnfeksiyonu Olan Hastalarda Oral Liken Planus Prevelansı. P-129.

XVI Ulusal Gastroenteroloji Kongresi, 10-15 Ekim 1999, Antalya 71) Tahan V, Ozaras R, Mert A, Çelik AF, Uzunismail H, Oktay E. İleri yaşta ciddi kolestatik hepatitle seyreden bir infeksiyöz mononükleoz olgusu, p 16. 72) Canbakan B, Dobrucalı A, Çelik A, Tahan V, Göksel S, Bal K, İlkova F, Tuncer M, Uzunismail H, Yurdakul İ, Oktay E, Hekim N, Dündar G. Cag A (+) ve (-) Helikobakter plori enfeksiyonunda gastrit lokalizasyonu ve gastroösofageal reflü insidansı, p 34.

I Ulusal İç Hastalıkları Kongresi, 03-07 Kasım 1999, Antalya 73) Tahan V, Özaras R, Tabak F, Mert A, Çelik AF, Özbay G, Uzunismail H, Senturk H, Oktay E, Aktuğlu Y. Erişkin yaş grubunda kolestatik hepatit ile seyreden dört infeksiyöz mononükleoz olgusu, p-28. 74) Özaras R, Mert A, Tabak F, Tahan V, Kanat M, Leblebici M, Aktuğlu Y. Glukoz-6-Fosfat Dehidrogenaz eksikliği olan bir hastada ağır hiperbilirubinemi ile seyreden bir A tipi akut viral hepatit olgusu, p-31. 75) Ayata E, Tahan V, Demir G, Özgüroğlu M, Molinas N, Demirelli F, Büyükünal E, Serdengeçti S, Berkarda B. Hodgkin lenfoma tanılı hastalarımızın değerlendirilmesi, p-36.

XV Gevher Nesibe Tıp Günleri, 27-30 Mayıs 1997, Kayseri 76) Özgüner MF, Serel TA, Delibaş N, Tahan V, Koyu A, Çalışkan S. The effect of melatonin on shock wave induced renal damage. P-35.

Yaşlanmaya Biokimyasal Yaklaşım Sempozyumu, 6-7 Kasım 1998, Ankara 77) Uzan S, Himmetoglu Ş, Aydın S, Uzun H, Tahan V, Özaras R, Dondurmacı S. Yaşlanma ve İnterlökin -6, p-8.

34 Ulusal Nöroloji Kongresi, Bursa, İstanbul 78) Apaydın S, Özaras R, Erek E, Tahan V, Çelik Y, Altıparmak MR, Çetinkaya A, Konuk N. Nefrotik sendromlu bir erişkinde klorambusile bağlı nöbet: Vaka taktimi.

1 Yıllk Kongresi, 6-10 Mayıs 1996, Nevşehir 79) Akkaya a, Şahin Ü, Ünlü M, Tahan V, Turgut E. Bronşiyal astımlı olgularda serum SOD ve MDA düzeylerinin araştırılması, p 76, Torks Derneği.

XXI Ulusal Endokrinoloji ve Metabolizma Hastalıkları Kongresi, 29 Eylül-3 Ekim 1998, İstanbul 80) Aydın S, Uzun H, Özaras R, Tahan V, Hatemi H, Dondurmacı S. Makrovasküler komplikasyonlu, Tip II diyabetiklerde sitokin profili ve lipid peroksidasyonu. p 78. 81) Uzun H, Aydın S, Tahan V, Özaras R, Dondurmacı S. Hatemi H, Mikroanjiopatili diabetik hastalarda sitokin düzeyleri ve lipid peroksidanyonu. p 79.

IV Ulusal Viral Hepatit Simpozyumu, 4-6 Kasım 1998, Ankara 82) Tahan V, Mert A, Özaras R, Tabak F, Akdoğan M, Şenturk H.Kronik hepatit B'li olguların çocuklarında hapatit B virus göstergeleri. p-28. 83) Tahan V, Tabak F, Özaras R, Mert A, Akdoğan M, Şenturk H. Kronik hepatit B havuzuna hangi yollarla hasta akmaktadır? p-29. 84) Tahan V, Tabak F, Özaras R, Mert A, Akdoğan M, Senturk H. Kronik hepatit C''li hastaların çocuklarında anti-HCV pozitifliği. p-66. 85) Tahan V, Tabak F, Özaras R, Mert A, Akdoğan M, Senturk H. Kronik hepatit C havuzuna hangi yollarla hasta akmaktadır? P-71. (Oral Presentation). 86) Özaras R, Mert A, Tahan V, Tabak F, Akdoğan M, Senturk H.Anti-HCV ve HCV-RNA pozitif, ALT normal olgularda karaciğer histology. p-65. 87) Özaras R, Tabak F, Mert A, Tahan V, Akdoğan M, Senturk H. Kronik hepatit D tedavisinde interferon uygulanmasının uzun dönem sonuçları. p-72. 88) Özaras R, Mert A, Senturk H, Tabak F, Tahan V, Akdoğan M, Aktuğlu Y. Sağlıklı HBs taşıyıcılarında HBV-DNA pozitiflik oranı. p-30. 89) Özaras R, Mert A, Senturk H, Tabak F, Tahan V, Başaranoğlu M, Aktuğlu Y. Kronik sağlıklı HBsAg taşıyıcılarının çeşitli yönlerden değerlendirilmesi. p-37.

XIII Ulusal Biyokimya Kongresi, 1996, Antalya 90) Delibaş N, Özcankaya R, Özgüner F, Akdoğan M, Tahan V. Bilişsel durum değişimleri ile kan lipid, lipoprotein ve apolipoprotein düzeylerinin ilişkisi. C-447.

K.B.B.'de Elektrofizyolojik Testler ve Kohlear Implantasyon Simpozyumu, 18-20 Mayıs 1995, Antalya 91) Delibaş N, Gedikli O, Doğru H, Akdoğan M, Tahan V. Gürültüye bağlı işitme kayıplarında serum lipid düzeyleri.